Edmund Waller MD/PhD/FACP
Academic Appointment
- Rein Saral, MD Professorship in Cancer Medicine, Winship Cancer Institute of Emory University
- Professor of Pathology, Emory University School of Medicine
- Professor of Hematology and Oncology, Winship Cancer Institute
- Professor of Medicine, Emory University School of Medicine
Education
Degrees
- MD from Cornell University Medical College
- PhD from The Rockefeller University
- BA from Harvard University
Research
Focus
- My research focuses on optimizing antitumor immunity in cancer patients. I have developed novel strategies of regulating immune responses by studying the interaction between T cells and dendritic cells in murine models and by using clinical samples from patients.
Publications
-
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
Blood Volume: 145 Page(s): 2138 - 2148
05/08/2025 Authors: Levis MJ; Hamadani M; Logan BR; Jones RJ; Singh AK; Litzow MR; Wingard JR; Papadopoulos EB; Perl AE; Soiffer RJ -
Rapid Modulation of Circulating Adipokines and Inflammatory Cytokines in Localized Prostate Cancer Following Short-Term Leuprolide Therapy.
Clin Genitourin Cancer Volume: 23 Page(s): 102358
04/14/2025 Authors: Yadalam AK; Chaudagar K; Mumme H; Bhasin M; Talekar GR; Waller EK; Lesinski GB; Patel SA; Mandawat A -
Transplanting Hope: Managing Relapsed/Refractory AML.
Clin Lymphoma Myeloma Leuk
04/08/2025 Authors: Funk CR; Waller EK -
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
Blood Adv Volume: 9 Page(s): 955 - 965
03/11/2025 Authors: Walters MC; Eapen M; Liu Y; El Rassi F; Waller EK; Levine JE; Strouse JJ; Antin JH; Parikh SH; Bakshi N -
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
02/20/2025 Authors: Zeng F; Zhang H; Wang S; Passang T; Li Y; Funk CR; Wyman S; O'Leary CB; Abousaud AI; Liu Y -
The unnecessary use of short tandem repeat testing on bone marrow samples in patients after 1 year following allogeneic hematopoietic stem cell transplant.
Am J Clin Pathol Volume: 162 Page(s): 464 - 470
11/04/2024 Authors: Morris AB; Sullivan HC; Wooten MS; Waller EK; Jaye DL -
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
Clin Cancer Res Volume: 30 Page(s): 4542
10/01/2024 Authors: Chung DJ; Shah N; Wu J; Logan B; Bisharat L; Callander N; Cheloni G; Anderson K; Chodon T; Dhakal B -
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer.
Cancer Res Volume: 84 Page(s): 2954 - 2967
09/16/2024 Authors: Passang T; Wang S; Zhang H; Zeng F; Hsu P-C; Wang W; Li J-M; Liu Y; Ravindranathan S; Lesinski GB -
Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
Int J Cardiol Volume: 407 Page(s): 132104
07/15/2024 Authors: Gold DA; Sandesara PB; Kindya B; Gold ME; Jain V; Vatsa N; Desai SR; Yadalam A; Razavi A; Elhage Hassan M -
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G-CSF and Plerixafor: A single center project.
J Clin Apher Volume: 39 Page(s): e22127
06/01/2024 Authors: Javanbakht A; Stringer S; Anderson H; Hamilton E; Philip A; Waller EK; Langston AA; Joseph N; Roback JD; Schneider T -
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
J Clin Oncol Volume: 42 Page(s): 1766 - 1775
05/20/2024 Authors: Levis MJ; Hamadani M; Logan B; Jones RJ; Singh AK; Litzow M; Wingard JR; Papadopoulos EB; Perl AE; Soiffer RJ -
Chemical Modifications to Enhance the Drug Properties of a VIP Receptor Antagonist (ANT) Peptide.
Int J Mol Sci Volume: 25
04/16/2024 Authors: Lester C; Li J-M; Passang T; Wang Y; Waller EK; Blakey SB -
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study.
Bone Marrow Transplant Volume: 59 Page(s): 334 - 343
03/01/2024 Authors: McCarthy PL; Attwood KM; Liu X; Chen GL; Minderman H; Alousi A; Bashey A; Lowsky R; Miklos DB; Hansen J -
Acute psychological stress-induced progenitor cell mobilization and cardiovascular events.
J Psychosom Res Volume: 178 Page(s): 111412
03/01/2024 Authors: Almuwaqqat Z; Wittbrodt M; Moazzami K; Garcia M; Lima B; Martini A; Sullivan S; Nye JA; Pearce BD; Shah AJ -
Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells.
Cancer Res Volume: 84 Page(s): 479 - 492
02/01/2024 Authors: Xia L; Liu J-Y; Yang M-Y; Zhang X-H; Jiang Y; Yin Q-Q; Luo C-H; Liu H-C; Kang Z-J; Zhang C-T -
Vitamin D Deficiency, Inflammation, and Diminished Endogenous Regenerative Capacity in Coronary Heart Disease.
JACC Adv Volume: 3 Page(s): 100804
02/01/2024 Authors: Desai SR; Ko Y-A; Liu C; Hafeez Z; Park J; Faaborg-Andersen C; Alvi Z; Alras Z; Alkhoder AA; Martini A -
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Transplant Cell Ther Volume: 30 Page(s): 114.e1 - 114.e16
01/01/2024 Authors: Papanicolaou GA; Chen M; He N; Martens MJ; Kim S; Batista MV; Bhatt NS; Hematti P; Hill JA; Liu H -
Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.
Volume: 142 Page(s): 1972 - 1984
12/07/2023 Authors: Shim J; Park S; Venkateswaran S; Kumar D; Prince C; Parihar V; Maples L; Waller EK; Kugathasan S; Briones M -
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
Clin Cancer Res Volume: 29 Page(s): 4784 - 4796
12/01/2023 Authors: Chung DJ; Shah N; Wu J; Logan B; Bisharat L; Callander N; Cheloni G; Anderson K; Chodon T; Dhakal B -
Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant (HCT) results in long-term sustained T cell activation and clonotypic expansion
Volume: 23 Page(s): S43 - S44
09/01/2023 Authors: Karagkouni D; Cheloni G; Torres D; Chung D; Shah N; Callander N; Chodon T; Efebera Y; Geller N; Hematti P -
Allogeneic Transplantation for AML Patients Without Morphological Remission: Current Challenges and Evolving Solutions
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 23 Page(s): S139 - S140
09/01/2023 Authors: Waller EK -
Orca-Q Demonstrates Favorable Graft-Versus-Host Disease (GvHD) and Relapse-Free Survival With Haploidentical Donors Without Post-Transplant Cyclophosphamide
Volume: 23 Page(s): S537 - S537
09/01/2023 Authors: Srour SA; Salhotra A; Lowsky R; Hoeg RT; Saad A; Waller EK; Pavlova A; McClellan JS; Fernhoff NB; Meyer EH -
Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease (GvHD) and Toxicity
Volume: 23 Page(s): S316 - S317
09/01/2023 Authors: Salhotra A; Oliai C; Hoeg RT; Gandhi A; Muffly L; Srour SA; Waller E; Lowsky R; Patel S; Pantin J -
Passenger pathogens on physicians.
Am J Infect Control Volume: 51 Page(s): 807 - 811
07/01/2023 Authors: Funk CR; Ravindranathan S; Matelski A; Zhang H; Taylor C; Chandrasekaran S; Arellano M; Langston AA; Joseph N; Waller EK -
Gene Expression Analysis Links Autocrine Vasoactive Intestinal Peptide and ZEB1 in Gastrointestinal Cancers.
Cancers (Basel) Volume: 15
06/22/2023 Authors: Rao IH; Waller EK; Dhamsania RK; Chandrasekaran S -
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results.
Blood Adv Volume: 7 Page(s): 2283 - 2286
06/13/2023 Authors: Jaeger U; Worel N; McGuirk JP; Riedell PA; Fleury I; Du Y; Han X; Pearson D; Redondo S; Waller EK -
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
J Clin Oncol Volume: 41 Page(s): 2227 - 2237
04/20/2023 Authors: Eapen M; Brazauskas R; Williams DA; Walters MC; St Martin A; Jacobs BL; Antin JH; Bona K; Chaudhury S; Coleman-Cowger VH -
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.
J Clin Oncol Volume: 41 Page(s): 1876 - 1887
04/01/2023 Authors: Miklos DB; Abu Zaid M; Cooney JP; Albring JC; Flowers M; Skarbnik AP; Yakoub-Agha I; Ko B-S; Bruno B; Waller EK -
Circulating progenitor cells and outcomes in patients with coronary artery disease.
Int J Cardiol Volume: 373 Page(s): 7 - 16
02/15/2023 Authors: Dhindsa DS; Desai SR; Jin Q; Sandesara PB; Mehta A; Liu C; Tahhan AS; Nayak A; Ejaz K; Hooda A -
mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias.
Blood Volume: 141 Page(s): 238 - 243
01/19/2023 Authors: Kumar D; Nguyen TH; Bennett CM; Prince C; Lucas L; Park S; Lawrence T; Chappelle K; Ishaq M; Waller EK -
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy.
Front Immunol Volume: 14 Page(s): 1154566
01/01/2023 Authors: Zhang H; Passang T; Ravindranathan S; Bommireddy R; Jajja MR; Yang L; Selvaraj P; Paulos CM; Waller EK -
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e1084 - e1091
12/01/2022 Authors: Romancik JT; Chen Z; Allen PB; Waller EK; Valla K; Colbert A; Rosand C; Palmer AF; Flowers CR; Cohen JB -
Donor NK cells facilitate thymopoiesis in allo-BMT.
Blood Volume: 140 Page(s): 2307 - 2308
12/01/2022 Authors: Waller EK -
The association between baseline circulating progenitor cells and vascular function: The role of aging and risk factors.
Vasc Med Volume: 27 Page(s): 532 - 541
12/01/2022 Authors: Moazzami K; Mehta A; Young A; Dhindsa DS; Martin G; Mokhtari A; Ghaini Hesaroieh I; Shah A; Bremner JD; Vaccarino V -
Donor plasmacytoid dendritic cells regulate GVHD and GVL activities of donor T cells in allogeneic hematopoietic stem cell transplantation
Volume: 57 Page(s): 44 - 44
11/01/2022 Authors: Das PK; Passang T; Zhu J; Wang Y; Li J; Nagy T; Gandhi K; Giver C; Ravindranathan S; Li J -
Overlap chronic graft-versus-host disease (GvHD) is associated aith an adverse prognosis: secondary analysis of the ABA2 trial
Volume: 57 Page(s): 41 - 41
11/01/2022 Authors: Gorfinkel L; Raghunandan S; Langston A; Westbrook A; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C -
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Nat Commun Volume: 13 Page(s): 6418
10/27/2022 Authors: Ravindranathan S; Passang T; Li J-M; Wang S; Dhamsania R; Ware MB; Zaidi MY; Zhu J; Cardenas M; Liu Y -
CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies.
Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S447
10/01/2022 Authors: Meyer E; Pavlova A; Gandhi A; Hoeg R; Oliai C; Mehta R; Srour S; McGuirk J; Waller E; Fernhoff N -
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.
Blood Volume: 140 Page(s): 1431 - 1447
09/22/2022 Authors: Zhu J; Wang Y; Li J; Das PK; Zhang H; Passang T; Li JM; Nagy T; Gandhi K; Ravindranathan S -
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
Cytotherapy Volume: 24 Page(s): 869 - 878
09/01/2022 Authors: Qayed M; McGuirk JP; Myers GD; Parameswaran V; Waller EK; Holman P; Rodrigues M; Clough LF; Willert J -
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.
Ophthalmol Sci Volume: 2 Page(s): 100176
09/01/2022 Authors: Sugar A; Hussain M; Chamberlain W; Dana R; Kelly DP; Ta C; Irvine J; Daluvoy M; Perez V; Olson J -
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv Volume: 6 Page(s): 4816 - 4820
08/23/2022 Authors: Jaeger U; Tam CS; Borchmann P; McGuirk JP; Johansen M; Waller EK; Jaglowski S; Andreadis C; Foley SR; Westin JR -
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12.
Sci Rep Volume: 12 Page(s): 11870
07/13/2022 Authors: Hunter R; Imbach KJ; Zhou C; Dougan J; Hamilton JAG; Chen KZ; Do P; Townsel A; Gibson G; Dreaden EC -
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis.
Bone Marrow Transplant Volume: 57 Page(s): 911 - 917
06/01/2022 Authors: Maakaron JE; Zhang M-J; Chen K; Abhyankar S; Bhatt VR; Chhabra S; El Jurdi N; Farag SS; He F; Juckett M -
CIRCULATING PROGENITOR CELL COUNT: AN INDEPENDENT BIOMARKER OF ADVERSE OUTCOMES IN CORONARY ARTERY DISEASE
Volume: 79 Page(s): 1003 - 1003
03/08/2022 Authors: Mehta A; Meng Q; Ahmad SF; Ho A; Desai S; Dhindsa D; Zuniga J; Islam S; Almuwaqqat Z; Nayak A -
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Blood Adv Volume: 6 Page(s): 746 - 749
02/08/2022 Authors: Qayed M; Watkins B; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C; Giller R; Grimley M -
PI3K/ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Blood Volume: 139 Page(s): 523 - 537
01/27/2022 Authors: Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A -
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
Blood Volume: 139 Page(s): 369 - 383
01/20/2022 Authors: Kumar D; Prince C; Bennett CM; Briones M; Lucas L; Russell A; Patel K; Chonat S; Graciaa S; Edington H -
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Blood Adv Volume: 6 Page(s): 339 - 357
01/11/2022 Authors: Wieduwilt MJ; Metheny L; Zhang M-J; Wang H-L; Estrada-Merly N; Marks DI; Al-Homsi AS; Muffly L; Chao N; Rizzieri D -
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Front Immunol Volume: 13 Page(s): 959658
01/01/2022 Authors: Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M -
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Blood Adv Volume: 5 Page(s): 4980 - 4991
12/14/2021 Authors: Thudium Mueller K; Grupp SA; Maude SL; Levine JE; Pulsipher MA; Boyer MW; August KJ; Myers GD; Tam CS; Jaeger U -
Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study.
Arterioscler Thromb Vasc Biol Volume: 41 Page(s): 2814 - 2822
11/01/2021 Authors: Almuwaqqat Z; Hwan Kim J; Garcia M; Ko Y-A; Moazzami K; Lima B; Sullivan S; Alkhalaf J; Mehta A; Shah AJ -
VASOACTIVE INTESTINAL PEPTIDE AS A NOVEL IMMUNE CHECKPOINT MOLECULE IN ACTIVATED T CELLS
Volume: 9 Page(s): A672 - A672
11/01/2021 Authors: Ravindranathan S; Fnu TP; Waller E -
TARGETING VASOACTIVE INTESTINAL PEPTIDE RECEPTOR SIGNALING IN PANCREATIC DUCTAL ADENOCARCINOMA FOR ENHANCED ANTI-TUMOR RESPONSE TO CHECKPOINT BLOCKADE
Volume: 9 Page(s): A779 - A781
11/01/2021 Authors: Ravindranathan S; Fnu TP; Li JM; Dhamsania R; Ware M; Zaidi M; Wang S; Zhu J; Cardenas M; Liu Y -
Microfluidic Platform to Transduce Cell Viability to Distinct Flow Pathways for High-Accuracy Sensing.
ACS Sens Volume: 6 Page(s): 3789 - 3799
10/22/2021 Authors: Chrit FE; Raj A; Young KM; Stone NE; Shankles PG; Lokireddy K; Flowers C; Waller EK; Alexeev A; Sulchek T -
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol Volume: 22 Page(s): 1403 - 1415
10/01/2021 Authors: Schuster SJ; Tam CS; Borchmann P; Worel N; McGuirk JP; Holte H; Waller EK; Jaglowski S; Bishop MR; Damon LE -
Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Volume: 21 Page(s): S396 - S397
09/01/2021 Authors: Santapuram P; Rupji M; Graiser M; Waller E; Blum K; Allen P; Koff J; Heffner L; Lechowicz M; Lonial S -
Overcoming TKI resistance in a patient with chronic myeloid leukemia using combination BCR-ABL inhibition with asciminib and bosutinib.
Am J Hematol Volume: 96 Page(s): E293 - E295
08/01/2021 Authors: Hall KH; Brooks A; Waller EK -
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica Volume: 106 Page(s): 2295 - 2296
08/01/2021 Authors: Lazaryan A; Dolan M; Zhang M-J; Wang H-L; Kharfan-Dabaja MA; Marks DI; Bejanyan N; Copelan E; Majhail NS; Waller EK -
Vasoactive Intestinal Peptide Receptor Signaling: A Novel and Targetable Immune Checkpoint Pathway in Pancreatic Cancer
Volume: 50 Page(s): 1091 - 1092
08/01/2021 Authors: Ravindranathan S; Tenzin P; Ware M; Zaidi M; Wang S; Dhamsania R; Zhu J; Liu Y; Liu Y; Gumber S -
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood Volume: 138 Page(s): 273 - 282
07/22/2021 Authors: Gooptu M; Romee R; St Martin A; Arora M; Al Malki M; Antin JH; Bredeson CN; Brunstein CG; Chhabra S; Fuchs EJ -
Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther Volume: 27 Page(s): 591 - 599
07/01/2021 Authors: Story CM; Wang T; Bhatt VR; Battiwalla M; Badawy SM; Kamoun M; Gragert L; Brown V; Baxter-Lowe LA; Marsh SGE -
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol Volume: 39 Page(s): 1865 - 1877
06/10/2021 Authors: Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S -
Vascular Regenerative Capacity and the Obesity Paradox in Coronary Artery Disease.
Arterioscler Thromb Vasc Biol Volume: 41 Page(s): 2097 - 2108
06/01/2021 Authors: Mehta A; Meng Q; Li X; Desai SR; D'Souza MS; Ho AH; Islam SJ; Dhindsa DS; Almuwaqqat Z; Nayak A -
Indole derivatives, microbiome and graft versus host disease.
Curr Opin Immunol Volume: 70 Page(s): 40 - 47
06/01/2021 Authors: Qayed M; Michonneau D; Soci G; Waller EK -
FIBRINOGEN-DEPLETED HUMAN PLATELET LYSATE MEDIA SUPPLEMENTATION PRODUCES SUPERIOR T CELL PRODUCT EX-VIVO
Volume: 23 Page(s): S199 - S199
05/01/2021 Authors: Chen KZ; Milligan W; Lin Y; Waller E -
Answer to May 2021 Photo Quiz.
J Clin Microbiol Volume: 59
04/20/2021 Authors: Modlin CE; Howard-Anderson J; Greer AM; Marchioli CE; Waller EK; Mehta AK; Burd EM; Kraft CS; Babiker A -
Photo Quiz: Strength in Numbers-a Disseminated Infection Causing Shortness of Breath.
J Clin Microbiol Volume: 59
04/20/2021 Authors: Modlin CE; Howard-Anderson J; Greer AM; Marchioli CE; Waller EK; Mehta AK; Burd EM; Kraft CS; Babiker A -
HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis.
Blood
04/13/2021 Authors: Gooptu M; Romee R; St Martin A; Arora M; Al Malki MM; Antin JH; Bredeson CN; Brunstein CG; Chhabra S; Fuchs EJ -
Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's disease.
Proc Natl Acad Sci U S A Volume: 118
03/16/2021 Authors: Ramesha S; Rayaprolu S; Bowen CA; Giver CR; Bitarafan S; Nguyen HM; Gao T; Chen MJ; Nwabueze N; Dammer EB -
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype.
J Thorac Oncol Volume: 16 Page(s): 464 - 476
03/01/2021 Authors: Owonikoko TK; Dwivedi B; Chen Z; Zhang C; Barwick B; Ernani V; Zhang G; Gilbert-Ross M; Carlisle J; Khuri FR -
Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
J Clin Apher Volume: 36 Page(s): 34 - 40
02/01/2021 Authors: Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC -
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K- and -.
Front Immunol Volume: 12 Page(s): 718621
01/01/2021 Authors: Chandrasekaran S; Funk CR; Kleber T; Paulos CM; Shanmugam M; Waller EK -
Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy iN Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial
Volume: 55 Page(s): 48 - 51
12/01/2020 Authors: Westin J; Tam C; Borchmann P; Jaeger U; McGuirk J; Holte H; Waller E; Jaglowski S; Bishop M; Andreadis C -
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
J Immunother Cancer Volume: 8
12/01/2020 Authors: Pakkala S; Higgins K; Chen Z; Sica G; Steuer C; Zhang C; Zhang G; Wang S; Hossain MS; Nazha B -
Vascular Regenerative Capacity: A Window into the Pathobiology of Obesity Paradox
Volume: 142
11/17/2020 Authors: Mehta A; Meng Q; Desai S; D'Souza M; Ho A; Islam S; Dhindsa DS; Nayak A; Alkhoder A; Hooda A -
Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens
Volume: 136
11/05/2020 Authors: Gooptu M; Martin AS; Romee R; Arora M; Al Malki MM; Antin JH; Bredeson C; Brunstein CG; Chhabra S; Fuchs EJ -
Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma
Volume: 136
11/05/2020 Authors: Romancik JT; Allen PB; Waller EK; Chen Z; Valla K; Dixon K; Reagan DJ; Colbert AB; Rosand C; Palmer A -
Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era
Volume: 136
11/05/2020 Authors: Santapuram PR; Rupji M; Graiser M; Waller EK; Blum KA; Allen PB; Koff JL; Heffner L; Lechowicz MJ; Lonial S -
DEVELOPING MORE POTENT INHIBITORS OF VASOACTIVE INTESTINAL PEPTIDE SIGNALING WITH ENHANCED EFFICACY IN MOUSE MODELS OF LEUKEMIA
Volume: 8 Page(s): A503 - A504
11/01/2020 Authors: Ravindranathan S; Li J-M; Li Y; Tenzin P; Majumdar A; Waller E -
Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination.
Science Volume: 370 Page(s): 237 - 241
10/09/2020 Authors: Davis CW; Jackson KJL; McCausland MM; Darce J; Chang C; Linderman SL; Chennareddy C; Gerkin R; Brown SJ; Wrammert J -
Kv1.3 Channel Expressing Brain Myeloid Cells are a Unique Pro-Inflammatory Subset of Microglia Which Can Be Modulated by Kv1.3 Blockers in Alzheimer's Pathology
Volume: 88 Page(s): S109 - S110
10/01/2020 Authors: Ramesha S; Gao T; Giver C; Rayaprolu S; Nwabueze N; Engstorm A; Xiao H; Pennati A; Katz D; Waller EK -
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia.
J Immunother Cancer Volume: 8
10/01/2020 Authors: Boyiadzis MM; Aksentijevich I; Arber DA; Barrett J; Brentjens RJ; Brufsky J; Cortes J; De Lima M; Forman SJ; Fuchs EJ -
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Br J Cancer Volume: 123 Page(s): 1228 - 1234
10/01/2020 Authors: Harvey RD; Carthon BC; Lewis C; Hossain MS; Zhang C; Chen Z; Harris WB; Alese OB; Shaib W; Bilen MA -
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant Volume: 26 Page(s): 1930 - 1936
10/01/2020 Authors: Solomon SR; Martin AS; Zhang M-J; Ballen K; Bashey A; Battiwalla M; Baxter-Lowe LA; Brunstein C; Chhabra S; Perez MAD -
Correlative analyses of patient and clinical characteristics associated with efficacy in tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma patients in the JULIET trial
Volume: 43 Page(s): 58 - 58
10/01/2020 Authors: Westin J; Tam CS; Borchmann P; Jaeger U; McGuirk JP; Holte H; Waller EK; Jaglowski S; Bishop MR; Andreadis C -
Correlation of Bridging Therapy (BT) and Lymphodepleting Chemotherapy (LDC) with clinical outcomes in patients (pts) with relapsed/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL) treated with tisagenlecleucel
Volume: 43 Page(s): 62 - 63
10/01/2020 Authors: Andreadis C; Tam CS; Borchmann P; Jaeger U; McGuirk JP; Holte H; Waller EK; Jaglowski S; Bishop MR; Foley SR -
Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy.
Sci Transl Med Volume: 12
09/30/2020 Authors: Francis DM; Manspeaker MP; Schudel A; Sestito LF; O'Melia MJ; Kissick HT; Pollack BP; Waller EK; Thomas SN -
Stiffness based enrichment of leukemia cells using microfluidics.
APL Bioeng Volume: 4 Page(s): 036101
09/01/2020 Authors: Islam M; Raj A; McFarland B; Brink HM; Ciciliano J; Fay M; Myers DR; Flowers C; Waller EK; Lam W -
Circulating Progenitor Cells in PatientsWith Coronary Artery Disease and Renal Insufficiency.
JACC Basic Transl Sci Volume: 5 Page(s): 770 - 782
08/01/2020 Authors: Mehta A; Tahhan AS; Liu C; Dhindsa DS; Nayak A; Hooda A; Moazzami K; Islam SJ; Rogers SC; Almuwaqqat Z -
Synergistic anti-tumor efficacy of the dual PI3K-delta/PI3K-gamma inhibitor duvelisib with PD-1 blockade in solid tumor and lymphoma models
Volume: 80
08/01/2020 Authors: Coma S; Funk CR; Wang S; Waller EK; Weaver DT; Pachter JA -
Turning up the heat on pancreatic ductal adenocarcinoma via inhibiting vasoactive intestinal peptide signaling
Volume: 80
08/01/2020 Authors: Ravindranathan S; Ware B; Zaidi M; Zhu J; Dhamsania RK; Wang S; Li Y; Rao IH; Thomas SN; Lesinski GB -
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
Blood Adv Volume: 4 Page(s): 3180 - 3190
07/14/2020 Authors: Zhou Z; Nath R; Cerny J; Wang H-L; Zhang M-J; Abdel-Azim H; Agrawal V; Ahmed G; Al-Homsi AS; Aljurf M -
Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
J Virol Volume: 94
06/16/2020 Authors: Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N -
Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study.
J Am Heart Assoc Volume: 9 Page(s): e015247
05/05/2020 Authors: Islam SJ; Kim JH; Topel M; Liu C; Ko Y-A; Mujahid MS; Sims M; Mubasher M; Ejaz K; Morgan-Billingslea J -
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica Volume: 105 Page(s): 1329 - 1338
05/01/2020 Authors: Lazaryan A; Dolan M; Zhang M-J; Wang H-L; Kharfan-Dabaja MA; Marks DI; Bejanyan N; Copelan E; Majhail NS; Waller EK -
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant Volume: 26 Page(s): 835 - 844
05/01/2020 Authors: Kebriaei P; Hayes J; Daly A; Uberti J; Marks DI; Soiffer R; Waller EK; Burke E; Skerrett D; Shpall E -
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
Contemp Clin Trials Volume: 91 Page(s): 105975
04/01/2020 Authors: Mehta A; Mavromatis K; Ko Y-A; Rogers SC; Dhindsa DS; Goodwin C; Patel R; Martini MA; Prasad M; Mokhtari A -
THE COMBINATION OF HEMATOPOIETIC AND ENDOTHELIAL PROGENITOR CELLS IMPROVES PREDICTION OF OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE
Volume: 75 Page(s): 162 - 162
03/24/2020 Authors: Dhindsa D; Sandesara P; Jin Q; Liu C; Mehta A; Alkhoder A; Tahhan AS; Mokhtari A; Hesaroieh I; Waller E -
IMPAIRED REGENERATIVE CAPACITY PREDICTS OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE AND RENAL INSUFFICIENCY
Volume: 75 Page(s): 3660 - 3660
03/24/2020 Authors: Mehta A; Tahhan AS; Liu C; Dhindsa D; Nayak A; Hooda A; Moazzami K; Islam S; Rogers S; Almuwaqqat Z -
Reduced Cardiovascular Regenerative Capacity is Associated With Enhanced Inflammatory Response to Acute Psychological Stress
Volume: 141
03/03/2020 Authors: Almuwaqqat Z; Kim JH; Hammadah M; Islam S; Lima BB; Hesaroieh I; Mokhtari A; Levantsevych O; Ejaz K; Shah AJ -
Evaluation of Tumor Vaccine Generation in a Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant (AutoHCT)Followed By Lenalidomide Maintenance for Multiple Myeloma (MM) with or without Vaccination with Dendritic Cell/ Myeloma Fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401
Volume: 26 Page(s): S62 - S63
03/01/2020 Authors: Avigan DE; Shah N; Logan B; Zhu J; Bisharat L; Callander NS; Chodon T; Dhakal B; Efebera YA; Geller N -
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv Volume: 4 Page(s): 629 - 637
02/25/2020 Authors: Maziarz RT; Waller EK; Jaeger U; Fleury I; McGuirk J; Holte H; Jaglowski S; Schuster SJ; Bishop MR; Westin JR -
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
Blood Adv Volume: 4 Page(s): 740 - 754
02/25/2020 Authors: Weisdorf D; Cooley S; Wang T; Trachtenberg E; Vierra-Green C; Spellman S; Sees JA; Spahn A; Vogel J; Fehniger TA -
A new role for an old cytokine: GM-CSF amplifies GVHD.
Blood Volume: 135 Page(s): 520 - 521
02/20/2020 Authors: Waller EK -
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
Blood Adv Volume: 4 Page(s): 560 - 572
02/11/2020 Authors: Awasthi R; Pacaud L; Waldron E; Tam CS; Jger U; Borchmann P; Jaglowski S; Foley SR; van Besien K; Wagner-Johnston ND -
Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
JAMA Cardiol Volume: 5 Page(s): 147 - 155
02/01/2020 Authors: Moazzami K; Lima BB; Hammadah M; Ramadan R; Al Mheid I; Kim JH; Alkhoder A; Obideen M; Levantsevych O; Shah A -
Daratumumab-associated hemophagocytic lymphohistiocytosis.
Ann Hematol Volume: 99 Page(s): 181 - 182
01/01/2020 Authors: Woods A; Wooten M; Thompson Heffner L; Waller E -
Circulating Progenitor Cells and Cognitive Impairment in Men and Women with Coronary Artery Disease.
J Alzheimers Dis Volume: 74 Page(s): 659 - 668
01/01/2020 Authors: Moazzami K; Wittbrodt MT; Lima BB; Kim JH; Hammadah M; Ko Y-A; Obideen M; Abdelhadi N; Kaseer B; Gafeer MM -
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
Mol Cancer Res Volume: 17 Page(s): 2395 - 2409
12/01/2019 Authors: Chandrasekaran S; Sasaki M; Scharer CD; Kissick HT; Patterson DG; Magliocca KR; Seykora JT; Sapkota B; Gutman DA; Cooper LA -
A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503
Volume: 134
11/13/2019 Authors: Eapen M; Neuberg DS; Mendizabal AM; Stevenson KE; Antin JH; DiFronzo N; El Rassi FA; Lulla P; Waller EK; Garrison J -
Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
Volume: 134
11/13/2019 Authors: Woods AC; Joseph N; Rupji M; Liu Y; Langston A; Waller EK -
Transplanted Vasoactive Intestinal Peptide-Secreting Donor Plasmacytoid Dendritic Cells Migrate to Lymphoid Organs and GvHD Target Organs
Volume: 134
11/13/2019 Authors: Zhu J; Wang Y; Li J; Li Y; Antonova AU; Giver CR; Li J; Wang S; Waller EK -
Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft
Volume: 134
11/13/2019 Authors: Gvajaia A; Langston A; Esiashvil N; Graiser M; Valla K; Waller EK -
Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease
Volume: 134
11/13/2019 Authors: Koreth J; Chhabra S; Pidala J; Shea TC; Jagasia M; Waller EK; Nakamura R; Mielcarek M; Chen GL; Meyers G -
Dual inhibition of PI3Kdelta and PI3Kgamma to enhance mitochondrial mass and ex vivo expansion of central and stem cell memory T cells from CLL patients
Volume: 7
11/06/2019 Authors: Funk C; Wang S; Waller A; Fleischer L; Sharma A; Spencer H; Gupta V; Ravindranathan S; Shanmugam M; Flowers C -
Vasoactive intestinal peptide: a novel checkpoint pathway in pancreatic ductal adenocarcinoma
Volume: 7
11/06/2019 Authors: Ravindranathan S; Wang S; Ware B; Zaidi M; Zhu J; Dhamsania R; Thomas S; Li Y; El-rayes B; Lesinski G -
Antagonism of signaling through the vasoactive intestinal peptide receptor as a novel immunotherapy in preclinical models of melanoma
Volume: 7
11/06/2019 Authors: Ravindranathan S; Wang S; Pankove R; Francis D; Thomas S; Dhamsania R; Pollack B; Waller E -
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Blood Adv Volume: 3 Page(s): 2836 - 2844
10/08/2019 Authors: Solomon SR; St Martin A; Shah NN; Fatobene G; Al Malki MM; Ballen KK; Bashey A; Bejanyan N; Bolaos Meade J; Brunstein CG -
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Biol Blood Marrow Transplant Volume: 25 Page(s): 2002 - 2007
10/01/2019 Authors: Waller EK; Miklos D; Cutler C; Arora M; Jagasia MH; Pusic I; Flowers MED; Logan AC; Nakamura R; Chang S -
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1744 - 1755
09/01/2019 Authors: Hamilton BK; Liu Y; Hemmer MT; Majhail N; Ringden O; Kim D; Costa L; Stuart R; Alousi A; Pidala JA -
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1875 - 1883
09/01/2019 Authors: Saad A; Lamb L; Wang T; Hemmer MT; Spellman S; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Agrawal V -
Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients
Volume: 19 Page(s): S251 - S252
09/01/2019 Authors: Bachanova V; Westin J; Tam C; Borchmann P; Jaeger U; McGuirk J; Holte H; Waller E; Jaglowski S; Bishop M -
The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.
Blood Adv Volume: 3 Page(s): 2465 - 2469
08/27/2019 Authors: Rashidi A; Luo X; Cooley S; Anasetti C; Waller EK; Brunstein CG; Cichocki F; Weisdorf DJ; Miller JS -
Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.
Blood Adv Volume: 3 Page(s): 2250 - 2263
08/13/2019 Authors: Waller EK; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Anasetti C; Fernando SM; Giver CR -
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.
Blood Adv Volume: 3 Page(s): 2230 - 2236
07/23/2019 Authors: Bishop MR; Maziarz RT; Waller EK; Jger U; Westin JR; McGuirk JP; Fleury I; Holte H; Borchmann P; Del Corral C -
Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy
Volume: 79
07/01/2019 Authors: Ravindranathan S; Li Y; Wang S; Zaidi MY; Lesinski GB; El-Rayes B; Waller EK -
Evaluation of in vivo chimeric antigen receptor (CAR) transgene levels in patients (pts) treated with tisagenlecleucel
Volume: 79
07/01/2019 Authors: Awasthi R; Mueller KT; Yanik GA; Tam CS; Rives S; McGuirk JP; Pulsipher MA; Boyer MW; Jaeger U; Baruchel A -
Vasoactive intestinal polypeptide synthesis induced in recipient somatic tissues prevents GVHD in allo-BMT
Volume: 54 Page(s): 338 - 339
07/01/2019 Authors: Waller E; Dhamsania R; Ravindranathan S; Li Y -
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1325 - 1330
07/01/2019 Authors: Prokopishyn NL; Logan BR; Kiefer DM; Sees JA; Chitphakdithai P; Ahmed IA; Anderlini PN; Beitinjaneh AM; Bredeson C; Cerny J -
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
Blood Adv Volume: 3 Page(s): 1826 - 1836
06/25/2019 Authors: Rashidi A; Hamadani M; Zhang M-J; Wang H-L; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M -
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1075 - 1084
06/01/2019 Authors: Hassan M; Ulezko Antonova A; Li JM; Hosoba S; Rupji M; Kowalski J; Perricone AJ; Jaye DL; Marsh H; Yellin M -
Personalized T cell therapy for metastatic colon cancer.
Volume: 37
05/20/2019 Authors: Ravindranathan S; Jajja MR; Waller A; Bommireddy R; Petersen C; Selvaraj P; Yang L; Lesinski GB; El-Rayes BF; Flynn B -
A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
Volume: 37
05/20/2019 Authors: Owonikoko TK; Higgins KA; Chen Z; Zhang C; Pillai RN; Steuer CE; Saba NF; Pakkala S; Shin DM; Zhang G -
Vasoactive intestinal peptide signaling - a novel immune checkpoint in pancreatic ductal adenocarcinoma
Volume: 202
05/01/2019 Authors: Ravindranathan S; Li Y; Wang S; Zaidi M; Lesinski GB; El-Rayes B; Waller EK -
Vasoactive intestinal polypeptide synthesis by somatic tissues in transplant recipients limits GVHD in allo-BMT
Volume: 202
05/01/2019 Authors: Li Y; Waller EK -
Graft plasmacytoid dendritic cells improve thymic function in allogeneic hematopoietic cell transplantation
Volume: 202
05/01/2019 Authors: Zhu J; Wang Y; Antonova AU; Li Y; Giver CR; Hassan M; Waller EK -
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Am J Hematol Volume: 94 Page(s): 446 - 454
04/01/2019 Authors: Krishnamurti L; Neuberg DS; Sullivan KM; Kamani NR; Abraham A; Campigotto F; Zhang W; Dahdoul T; De Castro L; Parikh S -
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant Volume: 25 Page(s): 699 - 711
04/01/2019 Authors: Pulsipher MA; Logan BR; Chitphakdithai P; Kiefer DM; Riches ML; Rizzo JD; Anderlini P; Leitman SF; Varni JW; Kobusingye H -
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica Volume: 104 Page(s): 844 - 854
04/01/2019 Authors: Pulsipher MA; Logan BR; Kiefer DM; Chitphakdithai P; Riches ML; Rizzo JD; Anderlini P; Leitman OF; Kobusingye H; Besser RM -
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
Blood Adv Volume: 3 Page(s): 875 - 883
03/26/2019 Authors: Chen Y-B; Le-Rademacher J; Brazauskas R; Kiefer DM; Hamadani M; DiPersio JF; Litzow MR; Craig M; Horwitz ME; Artz AS -
Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?
Cancer Volume: 125 Page(s): 838 - 842
03/15/2019 Authors: Koff JL; Waller EK -
CHANGE IN CIRCULATING PROGENITOR CELLS DURING STRESS TESTING AND RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE
Volume: 73 Page(s): 155 - 155
03/12/2019 Authors: Moazzami K; Lima B; Hammadah M; Alkhoder A; Ghaini I; Levantsevych O; Shah A; Bremner D; Kim J; Waller E -
Effect of Stem Cell Boost and Donor Lymphocyte Infusion on the Incidence of Graft-Versus-Host Disease at Emory University Hospital
Volume: 25
03/01/2019 Authors: Yoon J; Graiser M; Garcia M; Philip A; Waller EK -
Prolonged Improvement in Patient Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients (pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL): 19-Month Follow-up (FU) of the Juliet Study
Volume: 25
03/01/2019 Authors: Tam CS; Waller EK; Jaeger U; Fleury I; McGuirk J; Holte H; Jaglowski S; Schuster SJ; Bishop MR; Westin JR -
Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD.
Bone Marrow Transplant Volume: 54 Page(s): 490 - 493
03/01/2019 Authors: Rashidi A; Shanley R; Anasetti C; Waller EK; Scott BL; Blazar BR; Weisdorf DJ -
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
Biol Blood Marrow Transplant Volume: 25 Page(s): 270 - 278
02/01/2019 Authors: Alousi A; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Pidala J; Anderlini P; Boyiadzis M; Bredeson CN -
Author Correction: Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.
Nat Commun Volume: 10 Page(s): 372
01/17/2019 Authors: Nguyen DC; Garimalla S; Xiao H; Kyu S; Albizua I; Galipeau J; Chiang K-Y; Waller EK; Wu R; Gibson G -
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Cancer Volume: 125 Page(s): 185 - 193
01/15/2019 Authors: Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR -
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med Volume: 380 Page(s): 45 - 56
01/03/2019 Authors: Schuster SJ; Bishop MR; Tam CS; Waller EK; Borchmann P; McGuirk JP; Jger U; Jaglowski S; Andreadis C; Westin JR -
Sustained disease control and correlative analyses in tisagenlecleucel treated relapsed/refractory diffuse large B-Cell lymphoma patients (r/r DLBCL)
Volume: 42 Page(s): 238 - 238
01/01/2019 Authors: Borchmann P; Bachanova V; Westin J; Tam C; Jaeger U; McGuirk J; Holte H; Waller E; Jaglowski S; Bishop M -
Association Between Cardiovascular Health and Cognitive Performance: A Twins Study.
J Alzheimers Dis Volume: 71 Page(s): 957 - 968
01/01/2019 Authors: Kulshreshtha A; Goetz M; Alonso A; Shah AJ; Bremner JD; Goldberg J; Vaccarino V -
Individualized, Single Session Yoga Therapy to Reduce Physical and Emotional Symptoms in Hospitalized Hematological Cancer Patients.
Integr Cancer Ther Volume: 18 Page(s): 1534735419861692
01/01/2019 Authors: Mascaro JS; Waller AV; Wright L; Leonard T; Haack C; Waller EK -
KIR Donor Selection: Feasibility in Identifying better Donors.
Biol Blood Marrow Transplant Volume: 25 Page(s): e28 - e32
01/01/2019 Authors: Weisdorf D; Cooley S; Wang T; Trachtenberg E; Haagenson MD; Vierra-Green C; Spellman S; Spahn A; Vogel J; Kobusingye H -
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
Int J Mol Sci Volume: 19
12/19/2018 Authors: Funk CR; Petersen CT; Jagirdar N; Ravindranathan S; Jaye DL; Flowers CR; Langston A; Waller EK -
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
Blood Volume: 132 Page(s): 2506 - 2519
12/06/2018 Authors: Swimm A; Giver CR; DeFilipp Z; Rangaraju S; Sharma A; Ulezko Antonova A; Sonowal R; Capaldo C; Powell D; Qayed M -
A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.
Biol Blood Marrow Transplant Volume: 24 Page(s): 2373 - 2380
12/01/2018 Authors: Gandelman JS; Song DJ; Chen H; Engelhardt BG; Chen Y-B; Clark WB; Giver CR; Waller EK; Jung DK; Jagasia M -
Vasoactive Intestinal Peptide Synthesis in Transplant Recipients Critically Regulate Donor T Cell Alloreactivity and Graft-Versus Host Disease
Volume: 132
11/29/2018 Authors: Li Y; Waller EK -
T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes
Volume: 132
11/29/2018 Authors: Solomon SR; St Martin A; Shah NN; Fatobene G; Al Malki M; Ballen KK; Bashey A; Bejanyan N; Bolanos-Meade J; Brunstein CG -
Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients
Volume: 132
11/29/2018 Authors: Awasthi R; Mueller KT; Yanik GA; Tam CS; Rives S; McGuirk JP; Pulsipher MA; Boyer MW; Jaeger U; Baruchel A -
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.
Haematologica Volume: 103 Page(s): 1915 - 1924
11/01/2018 Authors: Carpenter PA; Logan BR; Lee SJ; Weisdorf DJ; Johnston L; Costa LJ; Kitko CL; Bolaos-Meade J; Sarantopoulos S; Alousi AM -
Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.
Nat Commun Volume: 9 Page(s): 3698
09/12/2018 Authors: Nguyen DC; Garimalla S; Xiao H; Kyu S; Albizua I; Galipeau J; Chiang K-Y; Waller EK; Wu R; Gibson G -
Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.
Br J Haematol Volume: 182 Page(s): 887 - 894
09/01/2018 Authors: Rashidi A; Shanley R; Yohe SL; Thyagarajan B; Curtsinger J; Anasetti C; Waller EK; Scott BL; Blazar BR; Weisdorf DJ -
Microfluidic generation of transient cell volume exchange for convectively driven intracellular delivery of large macromolecules.
Mater Today (Kidlington) Volume: 21 Page(s): 703 - 712
09/01/2018 Authors: Liu A; Islam M; Stone N; Varadarajan V; Jeong J; Bowie S; Qiu P; Waller EK; Alexeev A; Sulchek T -
FMS-like receptor tyrosine kinase 3 ligand treatment of bone marrow donors increases survival and GvT in allo-BMT recipients while reducing GvHD in murine transplant model
Volume: 53 Page(s): 144 - 144
09/01/2018 Authors: Hassan M; Ulezko A; Waller E -
Patient-Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 53 Page(s): 177 - 178
09/01/2018 Authors: Maziarz RT; Bishop MR; Tam CS; Borchmann P; Jaeger U; McGuirk J; Waller EK; Jaglowski S; Andreadis C; Foley SR -
Updated Results of a Phase 1b/2 Study of Ibrutinib in Chronic Graft Versus Host Disease After Failure of Prior Therapy
Volume: 53 Page(s): 71 - 73
09/01/2018 Authors: Waller EK; Miklos D; Cutler CS; Arora M; Jagasia M; Pusic I; Flowers ME; Logan AC; Nakamura R; Dubovsky J -
Circulating Progenitor Cells and Racial Differences.
Circ Res Volume: 123 Page(s): 467 - 476
08/03/2018 Authors: Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS -
Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.
Bone Marrow Transplant Volume: 53 Page(s): 1069 - 1071
08/01/2018 Authors: Rashidi A; Shanley R; Yohe SL; Thyagarajan B; Curtsinger J; Anasetti C; Waller EK; Miller JS; Blazar BR; Weisdorf DJ -
Clinical pharmacology of tisagenlecleucel (CTL019) in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
Volume: 78
07/01/2018 Authors: Awasthi R; Tam CS; Jaeger U; Jaglowski S; Foley SR; van Besien K; Wagner-Johnston ND; Kersten MJ; Schuster SJ; Salles G -
Impact of the posttransplant lymphoproliferative disorder subtype on survival.
Cancer Volume: 124 Page(s): 2327 - 2336
06/01/2018 Authors: Koff JL; Li J-X; Zhang X; Switchenko JM; Flowers CR; Waller EK -
Circulating progenitor cells in patients with familial hypercholesterolemia.
J Clin Apher Volume: 33 Page(s): 404 - 408
06/01/2018 Authors: Sandesara PB; Ramjee V; Ghasemzadeh N; Guo Y; Bhatia N; Li Q; Vaughn L; Nell-Dybdahl C; Waller EK; Mahar EA -
Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
Circ Res Volume: 122 Page(s): 1565 - 1575
05/25/2018 Authors: Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT -
Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).
Volume: 36
05/20/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff JL; Gupta VA; Lechowicz MJ; Nooka AK; Kaufman JL; Lonial S; Waller EK -
Considerations for tisagenlecleucel dosing rationale
Volume: 36
05/20/2018 Authors: Awasthi R; Mueller KT; Yanik GA; Tam CSL; Rives S; McGuirk J; Boyer MW; Jager U; Baruchel A; Myers GD -
Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients.
Volume: 36
05/20/2018 Authors: Mueller KT; Grupp SA; Maude SL; Levine JE; Pulsipher M; Boyer MW; August KJ; Myers GD; Awasthi R; Waldron EK -
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant Volume: 24 Page(s): 973 - 982
05/01/2018 Authors: Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD -
Vasoactive intestinal peptide synthesis in transplant recipients regulate donor T cell alloreactivity and graft-versus-host disease
Volume: 200
05/01/2018 Authors: Li Y; Waller EK -
Regulatory cells may not be the answer: A prospective study of ECP in cGVHD
Volume: 138 Page(s): S66 - S66
05/01/2018 Authors: Gandelman JS; Song D; Chen H; Engelhardt B; Chen Y; Clark W; Giver C; Waller E; Jagasia M -
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.
Blood Adv Volume: 2 Page(s): 933 - 940
04/24/2018 Authors: Shah NN; Ahn KW; Litovich C; Fenske TS; Ahmed S; Battiwalla M; Bejanyan N; Dahi PB; Bolaos-Meade J; Chen AI -
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.
Leuk Lymphoma Volume: 59 Page(s): 837 - 843
04/01/2018 Authors: Dhere V; Edelman S; Waller EK; Langston A; Graiser M; Connolly EC; Switchenko JM; Esiashvili N; Khan MK -
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
Biol Blood Marrow Transplant Volume: 24 Page(s): 521 - 528
03/01/2018 Authors: Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M -
Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
Volume: 24 Page(s): S135 - S136
03/01/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff J; Gupta V; Lechowicz M; Al-Kadhimi Z; Nooka A; Kaufman J; Lonial S -
A Prospective Trial of Extracorporeal Photopheresis (ECP) in the Modern Transplant Era Reveals Response and Decreased Steroid Doses for Patients with Chronic Graft-Versus-Host Disease
Volume: 24 Page(s): S180 - S181
03/01/2018 Authors: Gandelman JS; Song DJ; Chen H; Chen Y-B; Clark WB; Engelhardt BG; Giver CR; Waller EK; Jagasia M -
High Completion Rate of ECP Treatment in Patients with Chronic Graft-Versus-Host Disease Despite Unique Barriers: Lessons Learned From a Prospective Multicenter Trial
Volume: 24 Page(s): S268 - S269
03/01/2018 Authors: Song DJ; Gandelman JS; Chen Y-B; Clark WB; Engelhardt BG; Giver CR; Waller EK; Jagasia M -
Ibrutinib for Chronic Graft-Versus-Host Disease: A Safety and Pharmacokinetic Analysis in Patients Treated with Concomitant Antifungal CYP3A Inhibitors or Immunosuppressants
Volume: 24 Page(s): S186 - S187
03/01/2018 Authors: Cutler C; Jaglowski S; Arora M; Waller EK; Jagasia M; Pusic I; Flowers ME; Logan AC; Nakamura R; Clow F -
Ibrutinib-Mediated Inhibition of cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Thi T-Cells
Volume: 24 Page(s): S20 - S21
03/01/2018 Authors: Sahaf B; Tebaykin D; Hopper M; Cheung P; Bittencourt F; Cutler C; Arora M; Waller EK; Jagasia M; Pusic I -
Single Nucleotide Polymorphisms of Paneth Cell Antimicrobial Alpha Defensin-5 (DEFA5) are Associated with Acute Graft-Versus-Host Disease: Results From Analysis of BMT-CTN0201 Samples
Volume: 24 Page(s): S174 - S175
03/01/2018 Authors: Rashidi A; Shanley R; Holtan SG; MacMillan ML; Yohe S; Thyagarajan B; Curtsinger J; Anasetti C; Waller EK; Miller JS -
Myocardial Ischemia and Mobilization of Circulating Progenitor Cells.
J Am Heart Assoc Volume: 7 Page(s): e007504
02/20/2018 Authors: Hammadah M; Samman Tahhan A; Mheid IA; Wilmot K; Ramadan R; Kindya BR; Kelli HM; O'Neal WT; Sandesara P; Sullivan S -
Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy.
Cell Death Dis Volume: 9 Page(s): 239
02/14/2018 Authors: Islam M; Mezencev R; McFarland B; Brink H; Campbell B; Tasadduq B; Waller EK; Lam W; Alexeev A; Sulchek T -
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3K inhibitors and VIP antagonists.
Blood Adv Volume: 2 Page(s): 210 - 223
02/13/2018 Authors: Petersen CT; Hassan M; Morris AB; Jeffery J; Lee K; Jagirdar N; Staton AD; Raikar SS; Spencer HT; Sulchek T -
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
Blood Adv Volume: 2 Page(s): 299 - 307
02/13/2018 Authors: McCurdy SR; Zhang M-J; St Martin A; Al Malki MM; Bashey A; Gaballa S; Keesler DA; Hamadani M; Norkin M; Perales M-A -
Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
J Clin Pharmacol Volume: 58 Page(s): 7 - 24
01/01/2018 Authors: Kersh AE; Ng S; Chang YM; Sasaki M; Thomas SN; Kissick HT; Lesinski GB; Kudchadkar RR; Waller EK; Pollack BP -
An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
Volume: 41 Page(s): 36 - 37
01/01/2018 Authors: Borchmann P; Tam CS; Jaeger U; McGuirk JP; Holte H; Waller EK; Jaglowski SM; Bishop MR; Andreadis C; Foley SR -
The Potential of CAR T Cell Therapy in Pancreatic Cancer.
Front Immunol Volume: 9 Page(s): 2166
01/01/2018 Authors: Akce M; Zaidi MY; Waller EK; El-Rayes BF; Lesinski GB -
Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development.
Biomark Res Volume: 6 Page(s): 13
01/01/2018 Authors: Sanyi A; Jaye DL; Rosand CB; Box A; Shanmuganathan C; Waller EK -
Absence of Vasoactive Intestinal Peptide Synthesis in Recipients in Allogeneic Bone Marrow Transplant Increases Graft Versus Host Diseases
Volume: 130
12/07/2017 Authors: Li Y; Li J; Wang Y; Waller EK -
Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 130
12/07/2017 Authors: Awasthi R; Tam CS; Jaeger U; Jaglowski S; Foley SR; Van Besien K; Wagner-Johnston ND; Kersten MJ; Schuster SJ; Salles GA -
Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201
Volume: 130
12/07/2017 Authors: Fernando SM; Logan BR; Fei M; Lee SJ; Confer D; Howard A; Chandrakasan S; Giver CR; Anasetti C; Waller EK -
Reduced GvHD in Recipients of BM Derived Versus G-CSF Mobilized Plasmacytoid Dendritic Cells: Role of Inducible IL-12
Volume: 130
12/07/2017 Authors: Hassan M; Lin K; Ulezko A; Waller EK -
Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201
Volume: 130
12/07/2017 Authors: Waller EK; Logan BR; Fei M; Howard A; Wingard JR; Anasetti C; Giver CR -
Ibrutinib Inhibits cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells
Volume: 130
12/07/2017 Authors: Tebaykin BSD; Hopper M; Cheung P; Bittencourt F; Cutler CS; Arora M; Waller EK; Jagasia M; Pusic I; Flowers ME -
Graft Versus Host Disease Activity of Donor T Cells Is Regulated By Vasoactive Intestinal Polypeptide Synthesized By Donor Plasmacytoid Dendritic Cells
Volume: 130
12/07/2017 Authors: Wang Y; Li J; Li Y; Li J; Waller EK -
Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types
Volume: 130
12/07/2017 Authors: Giver CR; Mahar EA; Hosoba S; Kowalski J; Seby S; Zhang XA; Devine SM; Waller EK -
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
Blood Volume: 130 Page(s): 2243 - 2250
11/23/2017 Authors: Miklos D; Cutler CS; Arora M; Waller EK; Jagasia M; Pusic I; Flowers ME; Logan AC; Nakamura R; Blazar BR -
Nanoparticles to target tumor-draining lymph nodes conjugated with an antagonist for vasoactive intestinal peptide to promote an anti-tumor immune response
Volume: 5
11/07/2017 Authors: Pankove R; Ravindranathan S; Forghani P; Francis D; Thomas S; Waller E -
Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.
Oncotarget Volume: 8 Page(s): 81873 - 81879
10/10/2017 Authors: Forghani P; Petersen CT; Waller EK -
Sex Differences in Circulating Progenitor Cells.
J Am Heart Assoc Volume: 6
10/03/2017 Authors: Topel ML; Hayek SS; Ko Y-A; Sandesara PB; Samman Tahhan A; Hesaroieh I; Mahar E; Martin GS; Waller EK; Quyyumi AA -
Building blocks for institutional preparation of CTL019 delivery.
Cytotherapy Volume: 19 Page(s): 1015 - 1024
09/01/2017 Authors: McGuirk J; Waller EK; Qayed M; Abhyankar S; Ericson S; Holman P; Keir C; Myers GD -
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.
Volume: 52 Page(s): 1304 - 1310
09/01/2017 Authors: Al-Kadhimi Z; Gul Z; Abidi M; Lum LG; Deol A; Chen W; Jang H; Ozust C; Langston A; Waller E -
Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention
BONE MARROW TRANSPLANTATION Volume: 52 Page(s): 1304 - 1310
09/01/2017 Authors: Al-Kadhimi Z; Gul Z; Abidi M; Lum LG; Deol A; Chen W; Jang H; Ozust C; Langston A; Waller E -
Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.
Circ Heart Fail Volume: 10
08/01/2017 Authors: Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K -
Dose dependent association of early red blood cell transfusion with increased risk of graft versus host disease and worse survival after allogeneic hematopoietic stem cell transplantation
Volume: 52 Page(s): S207 - S208
07/01/2017 Authors: Waller EK; Hosoba S; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Easley KA; Josephson CD; Khoury HJ; Koff JL -
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS
Volume: 102
06/26/2017 Authors: Schuster SJ; Bishop MR; Tam C; Waller EK; Borchmann P; McGuirk J; Jaeger U; Jaglowski S; Andreadis C; Westin J -
IBRUTINIB FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER FAILURE OF FRONTLINE CORTICOSTEROIDS: RESULTS OF A MULTICENTER OPEN-LABEL PHASE 2 STUDY
Volume: 102 Page(s): 186 - 186
06/26/2017 Authors: Pusic I; Miklos D; Cutler C; Arora M; Waller E; Jagasia M; Flowers M; Logan A; Nakamura R; Blazar B -
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.
Infect Control Hosp Epidemiol Volume: 38 Page(s): 651 - 657
06/01/2017 Authors: Shah NN; McClellan W; Flowers CR; Lonial S; Khoury H; Waller EK; Langston A; Nooka AK -
Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy.
Volume: 35
05/20/2017 Authors: Petersen CT; Jagirdar N; Waller EK -
Microfluidic Sorting of Cells by Viability Based on Differences in Cell Stiffness.
Sci Rep Volume: 7 Page(s): 1997
05/17/2017 Authors: Islam M; Brink H; Blanche S; DiPrete C; Bongiorno T; Stone N; Liu A; Philip A; Wang G; Lam W -
Mobilizing plasmacytoid dendritic cells.
Blood Volume: 129 Page(s): 2600 - 2602
05/11/2017 Authors: Waller EK -
Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFN priming.
Blood Adv Volume: 1 Page(s): 628 - 643
04/25/2017 Authors: Chinnadurai R; Rajan D; Ng S; McCullough K; Arafat D; Waller EK; Anderson LJ; Gibson G; Galipeau J -
Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes.
Circ Res Volume: 120 Page(s): 1130 - 1138
03/31/2017 Authors: Hammadah M; Al Mheid I; Wilmot K; Ramadan R; Abdelhadi N; Alkhoder A; Obideen M; Pimple PM; Levantsevych O; Kelli HM -
CIRCULATING PROGENITOR CELLS LEVELS AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION
Volume: 69 Page(s): 288 - 288
03/21/2017 Authors: Tahhan AS; Almuwaqqat Z; Sandesara P; Alkhoder A; Stahl E; Heinl R; Hayek S; Kelli HM; Hammadah M; Topel M -
CENTRAL OBESITY PREDICTS CIRCULATING PROGENITOR CELL LEVELS
Volume: 69 Page(s): 1789 - 1789
03/21/2017 Authors: Khambhati J; Sandesara P; Tahhan AS; Topel M; Corrigan F; Kelli HM; Stahl E; Allard-Ratick M; Alkhoder A; Aida H -
ASSOCIATION BETWEEN CIRCULATING PROGENITOR CELLS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE
Volume: 69 Page(s): 60 - 60
03/21/2017 Authors: Sandesara P; Tahhan AS; Khambhati J; Stahl E; Hayek S; Hammadah M; Kelli HM; Topel M; Alkhoder A; Chivukula K -
PROGENITOR CELLS AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Volume: 69 Page(s): 928 - 928
03/21/2017 Authors: Tahhan AS; Sandesara P; Hayek S; Hammadah M; Allard-Ratick M; Kindya B; Kalogeropoulos A; Kelli HM; Topel M; Alkhoder A -
Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular Disease.
Stem Cells Transl Med Volume: 6 Page(s): 731 - 735
03/01/2017 Authors: Hayek SS; Klyachkin Y; Asfour A; Ghasemzadeh N; Awad M; Hesaroieh I; Ahmed H; Gray B; Kim J; Waller EK -
Safety and Engraftment Parameters for Bloodless Transplants among Myeloma Patients
Volume: 17 Page(s): E68 - E69
02/01/2017 Authors: Joseph N; Kaufman J; Boise L; Almaula D; Langston A; Waller E; Khoury H; Heffner LT; Lonial S; Nooka A -
Flow cytometric data analysis of circulating progenitor cell stability.
Data Brief Volume: 10 Page(s): 346 - 348
02/01/2017 Authors: Mahar EA; Mou L; Hayek SS; Quyyumi AA; Waller EK -
GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.
Mol Ther Volume: 25 Page(s): 416 - 426
02/01/2017 Authors: Deng J; Li Y; Pennati A; Yuan S; Wu JH; Waller EK; Galipeau J -
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
PLoS One Volume: 12 Page(s): e0184254
01/01/2017 Authors: Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li J-M; Waller EK -
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR -
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.
Oncoimmunology Volume: 6 Page(s): e1304336
01/01/2017 Authors: Petersen CT; Li J-M; Waller EK -
Presence of Vasoactive Intestinal Polypeptide Signaling in Plasmacytoid Dendritic Cells Improves Survival in a Murine Allo-BMT Model
Volume: 128
12/02/2016 Authors: Li J-X; Li J-M; Waller EK -
Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.
JAMA Oncol Volume: 2 Page(s): 1583 - 1589
12/01/2016 Authors: Lee SJ; Logan B; Westervelt P; Cutler C; Woolfrey A; Khan SP; Waller EK; Maziarz RT; Wu J; Shaw BE -
Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.
Cancer Res Volume: 76 Page(s): 6802 - 6815
12/01/2016 Authors: Li J-M; Petersen CT; Li J-X; Panjwani R; Chandra DJ; Giver CR; Blazar BR; Waller EK -
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.
Blood Volume: 128 Page(s): 2568 - 2579
11/24/2016 Authors: Furlan SN; Watkins B; Tkachev V; Cooley S; Panoskaltsis-Mortari A; Betz K; Brown M; Hunt DJ; Schell JB; Zeleski K -
Gender Differences in Circulating Progenitor Cells and Regenerative Capacity
Volume: 134
11/11/2016 Authors: Topel ML; Hayek SS; Ko Y-A; Martin GS; Waller EK; Quyyumi AA -
Telomere Shortening, Regenerative Capacity, and Cardiovascular Outcomes
Volume: 134
11/11/2016 Authors: Hammadah M; Al Mheid I; Wilmot K; Ramadan R; Abdelhadi N; Alkhoder A; Obideen M; Pimple P; Levantsevych O; Kelli HM -
Number of Circulating Progenitor Cells in Hypertensive Symptomatic Women With Non-obstructive CAD: a Substudy of NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Cardiovascular Disease Cohort (WISE-CVD)
Volume: 134
11/11/2016 Authors: Shahrivari M; Segal MS; Merz CNB; Quyyumi AA; Waller EK; Pepine CJ -
Bioactive Lipids and Circulating Progenitor Cells in Patients With Cardiovascular Disease.
Stem Cells Transl Med
10/14/2016 Authors: Hayek SS; Klyachkin Y; Asfour A; Ghasemzadeh N; Awad M; Hesaroieh I; Ahmed H; Gray B; Kim J; Waller EK -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia
Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia
Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Total Body Irradiation-Based Conditioning (TBI) Versus Chemotherapy-Based Conditioning (ChBC) for Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) for Acute Leukemia.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E493 - E494
10/01/2016 Authors: Edelman S; Waller EK; Graiser M; Langston AA; Dhere V; Mikell JL; Switchenko JM; Esiashvili N; Khan MK -
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
Atherosclerosis Volume: 253 Page(s): 111 - 117
10/01/2016 Authors: Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B -
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
Cancer Volume: 122 Page(s): 3005 - 3014
10/01/2016 Authors: Deol A; Sengsayadeth S; Ahn KW; Wang H-L; Aljurf M; Antin JH; Battiwalla M; Bornhauser M; Cahn J-Y; Camitta B -
Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors.
Volume: 119 Page(s): 801 - 809
09/16/2016 Authors: Al Mheid I; Hayek SS; Ko Y-A; Akbik F; Li Q; Ghasemzadeh N; Martin GS; Long Q; Hammadah M; Maziar Zafari A -
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
J Clin Oncol Volume: 34 Page(s): 3141 - 3149
09/10/2016 Authors: Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M -
Identification of Metabolomic Signatures that Correlate with Post-Transfusion Survival of Human RBCs
Volume: 56 Page(s): 24A - 25A
09/01/2016 Authors: Roback J; Zimring JC; Dumont LJ; Josephson C; Saakadze N; Barclay S; Waller EK; Jones DP; Maes LY; Wellington M -
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant Volume: 22 Page(s): 1636 - 1645
09/01/2016 Authors: Ballen K; Woo Ahn K; Chen M; Abdel-Azim H; Ahmed I; Aljurf M; Antin J; Bhatt AS; Boeckh M; Chen G -
Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFN Licensing.
Stem Cells Volume: 34 Page(s): 2429 - 2442
09/01/2016 Authors: Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J -
Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.
Circ Res Volume: 119 Page(s): 564 - 571
08/05/2016 Authors: Hayek SS; MacNamara J; Tahhan AS; Awad M; Yadalam A; Ko Y-A; Healy S; Hesaroieh I; Ahmed H; Gray B -
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
Clin Lymphoma Myeloma Leuk Volume: 16 Page(s): 466 - 471.e1
08/01/2016 Authors: DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R -
Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
Bone Marrow Transplant Volume: 51 Page(s): 1113 - 1120
08/01/2016 Authors: Ramanathan M; Teira P; Battiwalla M; Barrett J; Ahn KW; Chen M; Green J; Laughlin M; Lazarus HM; Marks D -
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Biol Blood Marrow Transplant Volume: 22 Page(s): 1197 - 1205
07/01/2016 Authors: Flowers CR; Costa LJ; Pasquini MC; Le-Rademacher J; Lill M; Shore TB; Vaughan W; Craig M; Freytes CO; Shea TC -
Inhibition of vasoactive intestinal polypeptide signaling augments T cell activation by plasmacytoid dendritic cells: implications for cellular immunotherapy
Volume: 196
05/01/2016 Authors: Li J; Li J-M; Waller EK -
Inhibition of CREB signaling through antagonism of vasoactive intestinal peptide enhances CD8 T cell function in a murine model of AML
Volume: 196
05/01/2016 Authors: Petersen CT; Li J-M; Waller EK -
Defining the optimal plasmacytoid dendritic cell graft source for hematopoietic stem cell transplantation
Volume: 196
05/01/2016 Authors: Hassan M; Lin K; Li J; Harris W; Waller EK -
Response to extracorporeal photopheresis in chronic graft versus host disease correlates with levels of IL-10 producing regulatory B cells
Volume: 196
05/01/2016 Authors: Chandra DJ; Hosoba S; Giver C; Waller EK -
SHORTER TELOMERE LENGTH IS ASSOCIATED WITH LOWER LEVELS OF CIRCULATING PROGENITOR CELLS
Volume: 67 Page(s): 166 - 166
04/05/2016 Authors: Hammadah M; Al Mheid I; Obideen M; Abdelhadi N; Wilmot K; Ramadan R; Alkhoder A; Pimple PM; Fang S; Awad M -
VITAMIN D3 LEVELS MODULATE CXCR4+CIRCULATING PROGENITOR CELL COUNTS
Volume: 67 Page(s): 2027 - 2027
04/05/2016 Authors: Hayek S; Ko Y-A; Al Mheid I; Hosny K; Ahmed H; Gray B; Patel K; Hesaroieh I; Martin G; Kim J -
Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.
Bone Marrow Transplant Volume: 51 Page(s): 607 - 609
04/01/2016 Authors: DeFilipp Z; Purcell M; Harris WAC; Chandra DJ; Gleason C; Wrammert J; Sarantopoulos S; Waller EK -
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Volume: 173 Page(s): 96 - 104
04/01/2016 Authors: Armand P; Kim HT; Sainvil M-M; Lange PB; Giardino AA; Bachanova V; Devine SM; Waller EK; Jagirdar N; Herrera AF -
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Previously Treated Germ Cell Tumors: A Single-Center Experience
Volume: 22 Page(s): S421 - S422
03/01/2016 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Waller EK -
Tailored Post-Transplant Maintenance with Tyrosine Kinase Inhibitors for High-Risk Philadelphia Chromosome-Positive Leukemia
Volume: 22 Page(s): S313 - S313
03/01/2016 Authors: DeFilipp Z; Langston AA; Kota VK; Al-Kadhimi Z; Jillella AP; Waller EK; Khoury HJ -
Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network
Volume: 22 Page(s): S50 - S52
03/01/2016 Authors: Carpenter PA; Logan BR; Lee SJ; Weisdorf DJ; Johnston L; Costa LJ; Kitko CL; Bolanos-Meade J; Alousi AM; Horowitz MM -
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?
Bone Marrow Transplant Volume: 51 Page(s): 333 - 343
03/01/2016 Authors: Auletta JJ; Devine SM; Waller EK -
Circulating Progenitor Cells is Linked to Cognitive Decline in Healthy Adults.
Am J Med Sci Volume: 351 Page(s): 147 - 152
02/01/2016 Authors: Hajjar I; Goldstein FC; Waller EK; Moss LD; Quyyumi A -
Collateral Blood Flow and Inflammatory Markers in Intracranial Atherosclerosis: Angiography and Biomarker Correlates in the BIOSIS and SAMMPRIS Trials
Volume: 47
02/01/2016 Authors: Liebeskind DS; Noreen SM; Long Q; Zhao Y; Quyyumi A; Le N-A; Waller EK; Cotsonis GA; Lynn MJ; Lane B -
The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.
Oncotarget Volume: 7 Page(s): 2936 - 2950
01/19/2016 Authors: Yang H; Brackett CM; Morales-Tirado VM; Li Z; Zhang Q; Wilson MW; Benjamin C; Harris W; Waller EK; Gudkov AV -
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital.
J Stem Cell Res Ther Volume: 6
01/01/2016 Authors: Yun HD; Dossul T; Bernal-Mizrachi L; Switchenko J; Ndibe C; Ibraheem A; Dixon MD; Langston AA; Nooka AK; Flowers CR -
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
J Immunother Cancer Volume: 4 Page(s): 90
01/01/2016 Authors: Boyiadzis M; Bishop MR; Abonour R; Anderson KC; Ansell SM; Avigan D; Barbarotta L; Barrett AJ; Van Besien K; Bergsagel PL -
Human Ige Plasma Cells In The Blood, Nasal Polyp, And The Bone Marrow Long Lived Plasma Cell Subset
Volume: 193
01/01/2016 Authors: Corrado A; Tipton C; Wise S; Chiang K-Y; Waller E; Sanz I; Lee F-H -
Clinically significant adverse events after major ABO mismatch BMT.
Bone Marrow Transplant Volume: 51 Page(s): 148 - 149
01/01/2016 Authors: Nickel RS; Waller EK; Qayed M; Chiang K-Y -
Absence of Vasoactive Intestinal Peptide Signaling Significantly Enhances T Cell Survival Following MCMV Infection Via Increased Expression of Bcl-2 and Bcl-XL
Volume: 126
12/03/2015 Authors: Petersen CT; Darlak KA; Li J-M; Waller EK -
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
Volume: 126
12/03/2015 Authors: Chen Y-B; Le-Rademacher J; Kiefer DM; Hamadani M; DiPersio JF; Litzow MR; Craig M; Horwitz ME; Artz A; McClune B -
MYd88 Blockade Caused Reduction of PDL1 on Tumor Infiltrating MDSCs in a Murine Model of Melanoma
Volume: 126
12/03/2015 Authors: Forghani P; Waller EK -
Lateral Gene Transfer Contributing to Leukemogenesis
Volume: 126
12/03/2015 Authors: Lee JH; Giver CR; Rangaraju S; Waller EK -
5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood
Volume: 126
12/03/2015 Authors: Lee SJ; Logan B; Westervelt P; Cutler CS; Woolfrey AE; Khan S; Waller EK; Maziarz RT; Wu J; Shaw BE -
Blocking VIP Signaling during Allogeneic Bone Marrow Transplantation Separates the Graft Versus Leukemia from Graft Versus Host Disease Activity of Donor CD8 T-Cells
Volume: 126
12/03/2015 Authors: Li J-M; Petersen CT; Li J; Giver CR; Blazar BR; Waller EK -
TLR5 Agonist Recombinant Flagellin, CBLB502 Increases Anti-CMV Immunity By Increasing T-Bet and Eomes Expressing T Cells after MCMV Infection
Volume: 126
12/03/2015 Authors: Hossain MS; Al-Kadhimi Z; Waller EK -
T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy
Volume: 126
12/03/2015 Authors: Li J; Panjwani R; Li J-M; Giver CR; Malone M; Waller EK -
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
Sci Transl Med Volume: 7 Page(s): 315ra191
11/25/2015 Authors: Furlan SN; Watkins B; Tkachev V; Flynn R; Cooley S; Ramakrishnan S; Singh K; Giver C; Hamby K; Stempora L -
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 694 - 698
11/01/2015 Authors: Flowers CR; Brown JR; Rosenthal H; Stock W; Katzen HI; Cohen JB; Sinha R; Lakhanpal S; Leis JF; Waller EK -
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial.
Transfusion Volume: 55 Page(s): 2351 - 2357
10/01/2015 Authors: Jagirdar N; Harvey RD; Nooka A; Flowers C; Kaufman J; Lonial S; Lechowicz MJ; Langston A; Lipscomb C; Gaylor C -
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 514 - 518
09/01/2015 Authors: Cohen JB; Bucur S; Winton EF; Sinha R; Heffner LT; King N; Lonial S; Langston AA; Waller EK; Hutchison-Rzepka A -
Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
Breast Cancer Res Treat Volume: 153 Page(s): 21 - 30
08/01/2015 Authors: Forghani P; Waller EK -
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR repertoire.
Blood Volume: 125 Page(s): 3835 - 3850
06/18/2015 Authors: Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M -
FUSOKINE GIFT4 TRIGGERS NOVEL B CELL FUNCTION ON HEMATOPOLETIC STEM CELLS
CYTOTHERAPY Volume: 17 Page(s): S13 - S14
06/01/2015 Authors: Deng J; Pennati A; Yuan S; Waller E; Lonial S; Roy K; Galipeau J -
BONE MARROW MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH ACUTE AND CHRONIC GVHD DEPLOY NORMAL PHENOTYPE, DIFFERENTIATION PLASTICITY AND IMMUNE-SUPPRESSIVE ACTIVITY
CYTOTHERAPY Volume: 17 Page(s): S39 - S39
06/01/2015 Authors: Copland IB; Qayed M; Garcia M; Galipeau J; Waller E -
Effect of Anti-angiogenic Agents Targeting Integrins alpha(v)beta(3) on human uveal melanoma and vascular endothelia
Volume: 56
06/01/2015 Authors: Yang H; Grossniklaus HE; Harris W; Zhang Q; Waller EK; Chakra R; Liu Z-R -
Effect of CD137 stimulation on ibrutinib antagonism of GA101 dependent NK cell-mediated cytotoxicity.
Volume: 33
05/20/2015 Authors: Rajasekaran N; Dutt S; Marabelle A; Houot R; Sadaram M; Hebb J; Sagiv-Barfi I; Ambulkar S; Rajapaksa AS; Chester C -
Improving Test Utilization for Chimerism Analysis After Hematopoietic Stem Cell Transplantation
Volume: 143 Page(s): A48 - A48
05/01/2015 Authors: Stelton C; Geller R; Waller E; Langston A; Gebel H; Jaye D -
A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency.
Clin Transl Immunology Volume: 4 Page(s): e37
05/01/2015 Authors: Hsieh J; Ng S; Bosinger S; Wu JH; Tharp GK; Garcia A; Hossain MS; Yuan S; Waller EK; Galipeau J -
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
Biol Blood Marrow Transplant Volume: 21 Page(s): 934 - 940
05/01/2015 Authors: Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK -
GVHD clears the Aire in thymic selection.
Blood Volume: 125 Page(s): 2593 - 2595
04/23/2015 Authors: Hassan MN; Waller EK -
Treating chemotherapy-induced thrombocytopenia: is it time for oncologists to use thrombopoietin agonists?
Oncology (Williston Park) Volume: 29 Page(s): 295 - 296
04/01/2015 Authors: Hassan MN; Waller EK -
New cancers after autotransplantations for multiple myeloma.
Biol Blood Marrow Transplant Volume: 21 Page(s): 738 - 745
04/01/2015 Authors: Mahindra A; Raval G; Mehta P; Brazauskas R; Zhang M-J; Zhong X; Bird JM; Freytes CO; Hale GA; Herzig R -
LOW ENDOTHELIAL PROGENITOR CELL (CD34+NEGFR2+) COUNT IS AN INDEPENDENT PREDICTOR OF PERIPHERAL ARTERIAL DISEASE
Volume: 65 Page(s): A2116 - A2116
03/17/2015 Authors: Hayek S; Tahhan AS; Yadalam A; MacNamara J; Awad M; Al Mheid I; Li Q; Waller E; Quyyumi A -
Plasmacytoid dendritic cells (pDC) from different allograft sources differ in expression of genes that regulate innate and adaptive immunity after allogeneic stem cell transplantation: implications for selection of the source of the stem cell graft
Volume: 50 Page(s): S63 - S64
03/01/2015 Authors: Waller EK; Harris W; Pauly R; Kowalski J; Logan B; Devine S; Rosenthal H; Hassan M; Lin K; Li J -
Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity.
PLoS Pathog Volume: 11 Page(s): e1004770
03/01/2015 Authors: Napier RJ; Norris BA; Swimm A; Giver CR; Harris WAC; Laval J; Napier BA; Patel G; Crump R; Peng Z -
Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress.
J Am Soc Hypertens Volume: 9 Page(s): 206 - 213
03/01/2015 Authors: Hayek SS; Poole JC; Neuman R; Morris AA; Khayata M; Kavtaradze N; Topel ML; Binongo JG; Li Q; Jones DP -
Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.
Int J Cardiol Volume: 182 Page(s): 387 - 389
03/01/2015 Authors: Hayek SS; Neuman R; Kavtaradze N; Sher S; Jones D; Li Q; Zhao L; Chen SC; Waller E; Quyyumi A -
Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.
Bone Marrow Transplant Volume: 50 Page(s): 432 - 437
03/01/2015 Authors: Gul Z; Van Meter E; Abidi M; Ditah I; Abdul-Hussein M; Deol A; Ayash L; Lum LG; Waller EK; Ratanatharathorn V -
Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.
Bone Marrow Transplant Volume: 50 Page(s): 465 - 468
03/01/2015 Authors: Zhang J; Mosunjac M; Moon A; Nooka A; Waller EK -
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Biol Blood Marrow Transplant Volume: 21 Page(s): 552 - 558
03/01/2015 Authors: Copelan EA; Avalos BR; Ahn KW; Zhu X; Gale RP; Grunwald MR; Hamadani M; Hamilton BK; Hale GA; Marks DI -
Evaluation of the spectra Optia mononuclear cell collection procedure in multiple myeloma patients.
J Clin Apher Volume: 30 Page(s): 1 - 7
02/01/2015 Authors: Long G; Waller EK; Gregurek S; Tricot G; Marschner S; Bill J -
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Leuk Lymphoma Volume: 56 Page(s): 383 - 389
02/01/2015 Authors: Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L -
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Volume: 21 Page(s): S69 - S70
02/01/2015 Authors: Suessmuth Y; Koura D; Finstermeier K; Desmarais C; Horan J; Langston A; Qayed M; Khoury HJ; Watkins BK; Robins H -
Defining the Primate T Cell Transcriptome during GvHD: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in GvHD Pathogenesis and Prevention
Volume: 21 Page(s): S56 - S56
02/01/2015 Authors: Furlan SN; Watkins BK; Mortari A; Blazar BR; Giver C; Waller EK; Kean LS -
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant Volume: 21 Page(s): 266 - 274
02/01/2015 Authors: Arai S; Arora M; Wang T; Spellman SR; He W; Couriel DR; Urbano-Ispizua A; Cutler CS; Bacigalupo AA; Battiwalla M -
Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.
Transfusion Volume: 55 Page(s): 259 - 264
02/01/2015 Authors: Hosoba S; Jaye DL; Cohen C; Roback JD; Waller EK -
Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.
Circ Res Volume: 116 Page(s): 289 - 297
01/16/2015 Authors: Patel RS; Li Q; Ghasemzadeh N; Eapen DJ; Moss LD; Janjua AU; Manocha P; Kassem HA; Veledar E; Samady H -
New Mechanism in Anti Tumor Activity of Poly (I:C): Modulation of Tumor-Associated Myeloid Derived Suppressor Cells in Murine Model of Breast Cancer
BLOOD Volume: 124
12/06/2014 Authors: Forghani P; Waller EK -
Dose and Time-Dependent Association of Red Blood Cell Transfusion with Increased Risk of GvHD and Worse Survival after Allogeneic HSCT
Volume: 124
12/06/2014 Authors: Hosoba S; Waller EK; Barclay S; Easley KA; Shenvi N; Roback J; Zimring JC; Giver CR -
Rituximab Administration before Allogeneic HSCT Is Associated with Accelerated T Cell Reconstitution after Transplantation: Kinetic Evidence for a Graft-Versus-Leukemia Effect
Volume: 124
12/06/2014 Authors: Hosoba S; Flowers CR; Wu CJ; Wrammert JR; Waller EK -
Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation
Volume: 124
12/06/2014 Authors: Yun HD; Dossul T; Bernal-Mizrachi L; Switchenko J; Ndibe C; Ibraheem A; Langston A; Pentz R; Waller EK -
Defining the Primate T Cell Transcriptome during Graft Versus Host Disease: New Data Implicating the Hedgehog and Aurora Kinase Pathways in Pathogenesis and Prevention
Volume: 124
12/06/2014 Authors: Furlan SN; Watkins B; Flynn RP; Ramakrishnan S; Singh K; Giver CR; Hanby K; Stempora L; Garrett AP; Ziegler CGK -
Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation
Volume: 124
12/06/2014 Authors: Waller EK; Giver CR; Rangaraju S; Swimm A; Sharma A; Qayed M; Defilipp Z; Kalman D -
Chemokine and lymph node homing receptor expression on pDC vary by graft source.
Oncoimmunology Volume: 3 Page(s): e958957
11/01/2014 Authors: Hosoba S; Harris WA; Lin KL; Waller EK -
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.
Biol Blood Marrow Transplant Volume: 20 Page(s): 1729 - 1736
11/01/2014 Authors: Hamadani M; Hari PN; Zhang Y; Carreras J; Akpek G; Aljurf MD; Ayala E; Bachanova V; Chen AI; Chen Y-B -
Circulating progenitor cells are reduced in HIV-positive, anti-retroviral nave patients.
Int J Cardiol Volume: 176 Page(s): 1150 - 1152
10/20/2014 Authors: Ghasemzadeh N; Zhang L; Al Mheid I; Li Q; Sperling L; Waller EK; Taylor WR; Guest J; Quyyumi AA; Mavromatis K -
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
Bone Marrow Transplant Volume: 49 Page(s): 1176 - 1183
09/01/2014 Authors: Fleischhauer K; Fernandez-Via MA; Wang T; Haagenson M; Battiwalla M; Baxter-Lowe LA; Ciceri F; Dehn J; Gajewski J; Hale GA -
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.
Blood Volume: 124 Page(s): 1372 - 1377
08/21/2014 Authors: Cutler C; Logan B; Nakamura R; Johnston L; Choi S; Porter D; Hogan WJ; Pasquini M; MacMillan ML; Hsu JW -
Incidence and geographic distribution of adult acute leukemia in the state of Georgia.
South Med J Volume: 107 Page(s): 497 - 500
08/01/2014 Authors: El Rassi F; Ward KC; Flowers CR; Heffner LT; Waller EK; Winton EF; Vaughn J; Hill BG; Langston A; Nooka A -
Improved survival after transplantation of more donor plasmacytoid dendritic or nave T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.
J Clin Oncol Volume: 32 Page(s): 2365 - 2372
08/01/2014 Authors: Waller EK; Logan BR; Harris WAC; Devine SM; Porter DL; Mineishi S; McCarty JM; Gonzalez CE; Spitzer TR; Krijanovski OI -
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant Volume: 20 Page(s): 951 - 959
07/01/2014 Authors: Wirk B; Fenske TS; Hamadani M; Zhang M-J; Hu Z-H; Akpek G; Aljurf MD; Armand P; Ayala E; Bachanova V -
Allotransplantation for patients age 40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
Biol Blood Marrow Transplant Volume: 20 Page(s): 960 - 968
07/01/2014 Authors: McClune BL; Ahn KW; Wang H-L; Antin JH; Artz AS; Cahn J-Y; Deol A; Freytes CO; Hamadani M; Holmberg LA -
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.
Biol Blood Marrow Transplant Volume: 20 Page(s): 979 - 985
07/01/2014 Authors: Al-Kadhimi Z; Gul Z; Chen W; Smith D; Abidi M; Deol A; Ayash L; Lum L; Waller EK; Ratanatharathorn V -
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.
Leuk Lymphoma Volume: 55 Page(s): 1498 - 1500
07/01/2014 Authors: Mitri Z; Siddiqui MT; El Rassi F; Holden JT; Heffner LT; Langston A; Waller EK; Winton E; McLemore M; Bernal-Mizrachi L -
Targeting CD137 enhances the efficacy of cetuximab.
J Clin Invest Volume: 124 Page(s): 2668 - 2682
06/01/2014 Authors: Kohrt HE; Colevas AD; Houot R; Weiskopf K; Goldstein MJ; Lund P; Mueller A; Sagiv-Barfi I; Marabelle A; Lira R -
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant Volume: 20 Page(s): 852 - 857
06/01/2014 Authors: Nooka AK; Johnson HR; Kaufman JL; Flowers CR; Langston A; Steuer C; Graiser M; Ali Z; Shah NN; Rangaraju S -
Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services.
Transfusion Volume: 54 Page(s): 1501 - 1507
06/01/2014 Authors: Howard A; Chitphakdithai P; Waller EK; Harris W; Rosenthal H; Nelson W; Majhail N; Navarro W; Waldvogel S; Lisy J -
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia.
Int J Radiat Oncol Biol Phys Volume: 89 Page(s): 360 - 369
06/01/2014 Authors: Mikell JL; Waller EK; Switchenko JM; Rangaraju S; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khoury HJ -
Circadian variation in vascular function and regenerative capacity in healthy humans.
J Am Heart Assoc Volume: 3 Page(s): e000845
05/15/2014 Authors: Al Mheid I; Corrigan F; Shirazi F; Veledar E; Li Q; Alexander WR; Taylor WR; Waller EK; Quyyumi AA -
Metabolomics of ADSOL (AS-1) red blood cell storage.
Transfus Med Rev Volume: 28 Page(s): 41 - 55
04/01/2014 Authors: Roback JD; Josephson CD; Waller EK; Newman JL; Karatela S; Uppal K; Jones DP; Zimring JC; Dumont LJ -
CIRCULATING PROGENITOR CELL LEVELS ARE HIGHER IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION COMPARED TO OTHER ACUTE CORONARY SYNDROME PRESENTATIONS
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Volume: 63 Page(s): A69 - A69
04/01/2014 Authors: Patel S; Ghasemzadeh N; Patel R; Li Q; Eapen D; Khayata M; Malekzadegan M; Smith G; Barde R; Awad M -
STROMAL CELL-DERIVED FACTOR 1-boxed times AND CIRCULATING PROGENITOR CELL LEVELS AS PREDICTORS OF ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Volume: 63 Page(s): A1589 - A1589
04/01/2014 Authors: Ghasemzadeh N; De Staercke C; Li Q; Eapen D; Khayata M; Malekzadegan M; Smith GH; Alzaranah B; Mekonnen G; Alanbari R -
Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer.
Cancer Med Volume: 3 Page(s): 215 - 224
04/01/2014 Authors: Forghani P; Khorramizadeh MR; Waller EK -
CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.
Blood Volume: 123 Page(s): 1967 - 1969
03/20/2014 Authors: Kaliyaperumal S; Watkins B; Sharma P; Furlan S; Ramakrishnan S; Giver C; Garcia A; Courtney C; Knight H; Strobert E -
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
Leukemia Volume: 28 Page(s): 658 - 665
03/01/2014 Authors: Bachanova V; Marks DI; Zhang M-J; Wang H; de Lima M; Aljurf MD; Arellano M; Artz AS; Bacher U; Cahn J-Y -
TARGETING THE ARYL HYDROCARBON RECEPTOR WITH AN ORAL INDOLE DERIVATIVE TO PREVENT GASTROINTESTINAL GVHD.
Volume: 49 Page(s): S20 - S20
03/01/2014 Authors: Waller EK; Giver CA; Rangaraju S; Swimm A; Sharma A; Quayed M; Kalman D -
Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation.
J Hematol Oncol Volume: 7 Page(s): 16
02/28/2014 Authors: Darlak KA; Wang Y; Li J-M; Harris WA; Giver CR; Huang C; Waller EK -
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
Blood Volume: 123 Page(s): 1270 - 1278
02/20/2014 Authors: Fernandez-Via MA; Wang T; Lee SJ; Haagenson M; Aljurf M; Askar M; Battiwalla M; Baxter-Lowe L-A; Gajewski J; Jakubowski AA -
CD8-Predominant T Cell Meningitis Accompanies Gvhd in Primates and Is Prevented with Immunoprophylaxis
Volume: 20 Page(s): S270 - S272
02/01/2014 Authors: Kaliyaperumal S; Sharma P; Watkins BK; Furlan SN; Ramakrishnan S; Giver C; Garcia A; Courtney C; Hamby K; Garrett A -
Simplified Technique for Administration of High Dose Melphalan
Volume: 20 Page(s): S291 - S292
02/01/2014 Authors: Hutcherson D; Valla K; Shah KS; Surati M; French K; Nooka A; Kaufman J; Lonial S; Cohen JB; Langston A -
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.
Biol Blood Marrow Transplant Volume: 20 Page(s): 202 - 208
02/01/2014 Authors: Warlick ED; Paulson K; Brazauskas R; Zhong X; Miller AM; Camitta BM; George B; Savani BN; Ustun C; Marks DI -
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
Bone Marrow Transplant Volume: 49 Page(s): 185 - 189
02/01/2014 Authors: Langston AA; Prichard JM; Muppidi S; Nooka A; Lechowicz MJ; Lonial S; Sinha R; Graiser M; Kaufman JL; Khoury HJ -
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.
J Clin Oncol Volume: 32 Page(s): 273 - 281
02/01/2014 Authors: Fenske TS; Zhang M-J; Carreras J; Ayala E; Burns LJ; Cashen A; Costa LJ; Freytes CO; Gale RP; Hamadani M -
New molecule for mobilizing marrow stem cells.
Blood Volume: 123 Page(s): 310 - 311
01/16/2014 Authors: Hosoba S; Waller EK -
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant Volume: 20 Page(s): 89 - 97
01/01/2014 Authors: Gupta V; Malone AK; Hari PN; Ahn KW; Hu Z-H; Gale RP; Ballen KK; Hamadani M; Olavarria E; Gerds AT -
Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.
PLoS One Volume: 9 Page(s): e96165
01/01/2014 Authors: Hossain MS; Ramachandiran S; Gewirtz AT; Waller EK -
Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
JAMA Volume: 310 Page(s): 2631 - 2639
12/25/2013 Authors: Poole J; Mavromatis K; Binongo JN; Khan A; Li Q; Khayata M; Rocco E; Topel M; Zhang X; Brown C -
Effect of Progenitor Cell Mobilization with Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Patients with Peripheral Artery Disease and Claudication; GPAD-II: A Phase II Randomized Study
CIRCULATION Volume: 128 Page(s): 2714 - 2715
12/17/2013 Authors: Poole J; Mavromatis K; Binongo J; Khan A; Li Q; Khayata M; Rocco E; Neuman R; Morris A; Topel M -
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.
Blood Volume: 122 Page(s): 3863 - 3870
12/05/2013 Authors: Copelan EA; Hamilton BK; Avalos B; Ahn KW; Bolwell BJ; Zhu X; Aljurf M; van Besien K; Bredeson C; Cahn J-Y -
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.
Cancer Volume: 119 Page(s): 4119 - 4128
12/01/2013 Authors: Nooka AK; Kaufman JL; Behera M; Langston A; Waller EK; Flowers CR; Gleason C; Boise LH; Lonial S -
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 13 Page(s): 657 - 663
12/01/2013 Authors: Sinha R; Shenoy PJ; King N; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman J; Heffner LT -
Increased Circulating Progenitor Cells in Women With Microvascular Coronary Dysfunction: Results From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
Volume: 128
11/26/2013 Authors: Mekonnen G; Mehta PK; Li Q; Kenkre TS; Ghasemzadeh N; Petersen JW; Azarbal B; Samuels B; Anderson D; Anderson D -
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
J Clin Oncol Volume: 31 Page(s): 4199 - 4206
11/20/2013 Authors: Armand P; Nagler A; Weller EA; Devine SM; Avigan DE; Chen Y-B; Kaminski MS; Holland HK; Winter JN; Mason JR -
Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America
Volume: 122
11/15/2013 Authors: Flowers CR; Lill M; Costa LJ; Shore TB; Vaughan W; Craig M; Freytes CO; Shea TC; Horwitz ME; Fay JW -
Expression Of PD-L1 Is Required To Control Acute GvHD In Allo-HSCT Recipients
Volume: 122
11/15/2013 Authors: Hossain MS; El-Najjar VF; Jaye DL; Ahmed R; Waller EK -
Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients
Volume: 122
11/15/2013 Authors: Shah NN; Nooka AK; Kaufman JL; Casbourne D; Hutcherson D; Maynard R; Waller EK; Lonial S; Langston A -
Pharmacological Inhibition Of Semi-Direct Alloantigen Presentation and The Generation Of Cross-Dressed Antigen Presenting Cells: A Novel approach To Limit Graft Versus Host Disease Following Allogeneic Hematopoetic Stem Cell Transplantation
Volume: 122
11/15/2013 Authors: Rangaraju S; Choi J; Giver CR; Waller EK -
Allogeneic HSCT Patients Receiving More RBC Transfusions Are At Increased Risk For Development Of Grade 2-4 Acute Graft-Versus-Host Disease
Volume: 122
11/15/2013 Authors: Giver CR; Ali Z; Barclay S; Hosaba S; Li Q; Roback J; Waller EK -
Blocking VIP Signaling Abrogates Upregulation Of PD1 and Increases Proliferation Of Allo-Reactive T-Cells In a Mixed Lymphocyte Reaction
Volume: 122
11/15/2013 Authors: Summerbell ER; Giver CR; Rangaraju S; Darlak KA; Waller EK -
VIP-Receptor Antagonist Enhanced Antileukemic Activity In Mice
Volume: 122
11/15/2013 Authors: Li J-M; Petersen CT; Darlak KA; Yun HD; Blazar BR; Waller EK -
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1615 - 1624
11/01/2013 Authors: Costa LJ; Zhang M-J; Zhong X; Dispenzieri A; Lonial S; Krishnan A; Freytes C; Vesole D; Gale RP; Anderson K -
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1638 - 1649
11/01/2013 Authors: Koura DT; Horan JT; Langston AA; Qayed M; Mehta A; Khoury HJ; Harvey RD; Suessmuth Y; Couture C; Carr J -
Providing personalized prognostic information for adult leukemia survivors.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1600 - 1607
11/01/2013 Authors: Lee SJ; Storer B; Wang H; Lazarus HM; Waller EK; Isola LM; Klumpp TR; Umejiego JBC; Savani BN; Loren AW -
Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia
Volume: 87 Page(s): S558 - S558
10/01/2013 Authors: Mikell JL; Waller EK; Rangaraju S; Switchenko JM; Ali Z; Graiser M; Hall WA; Langston AA; Esiashvili N; Khan MK -
The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.
Biomaterials Volume: 34 Page(s): 7840 - 7850
10/01/2013 Authors: Copland IB; Garcia MA; Waller EK; Roback JD; Galipeau J -
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
Br J Haematol Volume: 162 Page(s): 648 - 656
09/01/2013 Authors: Maziarz RT; Wang Z; Zhang M-J; Bolwell BJ; Chen AI; Fenske TS; Freytes CO; Gale RP; Gibson J; Hayes-Lattin BM -
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1393 - 1395
09/01/2013 Authors: Harvey RD; Kaufman JL; Johnson HR; Nooka A; Vaughn L; Flowers CR; Khoury HJ; Lechowicz MJ; Langston AA; Lonial S -
Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1331 - 1339
09/01/2013 Authors: Darlak KA; Wang Y; Li J-M; Harris WAC; Owens LM; Waller EK -
Higher Baseline Progenitor Cell Counts in Familial Hypercholesterolemic Patients Compared to Healthy Controls
Volume: 113
08/01/2013 Authors: Ramjee V; Bhatia N; Ghasemzadeh N; Guo Y; Li Q; Vaughn L; Nell-Dybdahl C; Waller EE; Brigham K; Wilson PW -
Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia.
Blood Volume: 122 Page(s): 474
07/25/2013 Authors: Yun HD; Waller EK -
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1102 - 1108
07/01/2013 Authors: Foran JM; Pavletic SZ; Logan BR; Agovi-Johnson MA; Prez WS; Bolwell BJ; Bornhuser M; Bredeson CN; Cairo MS; Camitta BM -
ELIMINATING THE NEED FOR 24-HOUR URINE STUDIES IN PHASE I MYELOMA PATIENTS
Volume: 98 Page(s): 598 - 598
06/12/2013 Authors: Shah N; Kaufman J; Langston A; Waller E; Boise L; Harvey R; Lonial S; Nooka A -
Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM)
Volume: 31
05/20/2013 Authors: Nooka AK; Langston AA; Waller EK; Heffner LT; Gleason C; Muppidi S; Watson M; Casbourne D; Boise L; Kaufman JL -
Outcomes of hematopoietic stem cell transplant recipients admitted to the medical intensive care unit.
Volume: 31
05/20/2013 Authors: Duc QT; Langston AA; Waller EK; Simon M; Gleason C; Casbourne D; Fisher M; Kaufman JL; Flowers C; Lonial S -
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.
Biol Blood Marrow Transplant Volume: 19 Page(s): 741 - 745
05/01/2013 Authors: Dobbelstein C; Ahn KW; Haagenson M; Hale GA; van Rood JJ; Miklos D; Waller EK; Spellman SR; Fernandez-Vina M; Ganser A -
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.
Biol Blood Marrow Transplant Volume: 19 Page(s): 746 - 753
05/01/2013 Authors: Hamadani M; Saber W; Ahn KW; Carreras J; Cairo MS; Fenske TS; Gale RP; Gibson J; Hale GA; Hari PN -
MISMATCHES FOR HLA-C*03:03/03:04 MAY BE BETTER TOLERATED THAN OTHER MISMATCHES IN UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
Volume: 81 Page(s): 292 - 293
05/01/2013 Authors: Fernandez-Vina MA; Wang T; Lee SJ; Haagenson M; Aljurf M; Askar M; Battiwalla M; Baxter-Lowe L-A; Gajewski J; Jakubowski A -
Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.
Cancer Volume: 119 Page(s): 1503 - 1511
04/15/2013 Authors: Owonikoko TK; Hossain MS; Bhimani C; Chen Z; Kim S; Ramalingam SS; Sun S-Y; Shin DM; Waller EK; Khuri FR -
Blocking VIP-signalling after allogeneic bone marrow transplantation (allo-BMT) enhances the cytotoxic graft-versus-leukaemia activity of donor T-cells
Volume: 48 Page(s): S68 - S68
04/01/2013 Authors: Waller E; Yun HD; Li JM -
Single centre pharmacoeconomic analysis of palifermin in autologous stem cell transplantation
Volume: 48 Page(s): S453 - S453
04/01/2013 Authors: Johnson HR; Nooka A; Kaufman J; Flowers C; Langston A; Graiser M; Plummer T; Lonial S; Waller E -
Finding the sweet spot for donor lymphocyte infusions.
Biol Blood Marrow Transplant Volume: 19 Page(s): 507 - 508
04/01/2013 Authors: Yun HD; Waller EK -
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant Volume: 19 Page(s): 625 - 631
04/01/2013 Authors: Hamadani M; Saber W; Ahn KW; Carreras J; Cairo MS; Fenske TS; Gale RP; Gibson J; Hale GA; Hari PN -
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.
Leuk Lymphoma Volume: 54 Page(s): 708 - 713
04/01/2013 Authors: Vose JM; Friedberg JW; Waller EK; Cheson BD; Juvvigunta V; Fritsch H; Petit C; Munzert G; Younes A -
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
Blood Volume: 121 Page(s): 2567 - 2573
03/28/2013 Authors: Alousi AM; Le-Rademacher J; Saliba RM; Appelbaum FR; Artz A; Benjamin J; Devine SM; Kan F; Laughlin MJ; Lazarus HM -
Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.
Blood Volume: 121 Page(s): 2347 - 2351
03/21/2013 Authors: Li J-M; Hossain MS; Southerland L; Waller EK -
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 460 - 467
03/01/2013 Authors: Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK -
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Volume: 19 Page(s): S139 - S139
02/01/2013 Authors: Kozyr N; Ramakrishnan S; Polnett A; Hamby K; Tiwari D; Watkins B; Deane T; Stempora L; Elder E; Esiashvili N -
Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America
Volume: 19 Page(s): S132 - S132
02/01/2013 Authors: Lill M; Costa LJ; Yeh RF; Lim S; Stuart R; Waller EK; Shore T; Craig M; Freytes CO; Shea TC -
A First-in-Disease Trial of in Vivo Costimulation Blockade for GVHD Prevention: The Addition of Abatacept to Standard GVHD Prophylaxis Controls Early CD4+T Cell Proliferation and is Associated with Low Rates of Severe Acute GVHD
Volume: 19 Page(s): S327 - S328
02/01/2013 Authors: Tiwari D; Horan J; Langston A; Qayed M; Carr J; Renfroe H; Couture C; Khoury HJ; Robertson J; Harvey D -
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Volume: 19 Page(s): S191 - S191
02/01/2013 Authors: Waller EK; Johnson HR; Jagirdar N; Gaylor C; Lipscomb C; Flowers C; Kaufman J; Khoury HJ; Langston A; Lechowicz M -
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood Volume: 121 Page(s): 197 - 206
01/03/2013 Authors: Pulsipher MA; Chitphakdithai P; Logan BR; Shaw BE; Wingard JR; Lazarus HM; Waller EK; Seftel M; Stroncek DF; Lopez AM -
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma.
Transfusion Volume: 53 Page(s): 76 - 84
01/01/2013 Authors: Kaufman JL; Flowers CR; Rados KD; Calandra GB; Vose JM; Hewes LB; Lonial S; Langston AA; Khoury HJ; Lechowicz MJ -
Tools to optimize the functionality of a leukemia clinical trial team.
Leuk Lymphoma Volume: 54 Page(s): 110 - 116
01/01/2013 Authors: Bethelmie-Bryan B; Lord K; Holloway S; Safavi F; Shepard M; Rogers S; Harvey RD; Rodger K; Waller EK; El-Rayes B -
Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.
PLoS One Volume: 8 Page(s): e64837
01/01/2013 Authors: Forghani P; Harris W; Giver CR; Mirshafiey A; Galipeau J; Waller EK -
VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.
PLoS One Volume: 8 Page(s): e63381
01/01/2013 Authors: Li J-M; Darlak KA; Southerland L; Hossain MS; Jaye DL; Josephson CD; Rosenthal H; Waller EK -
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases.
Biomed Res Int Volume: 2013 Page(s): 929842
01/01/2013 Authors: Chinnadurai R; Waller EK; Galipeau J; Nooka AK -
Hematopoietic Progenitor Cells Expressing CD34+and CD133+Surface Markers are Predictors of Adverse Cardiovascular Outcomes in a Population with Coronary Artery Disease
CIRCULATION Volume: 126
11/20/2012 Authors: Patel RS; Eapen DJ; Li Q; Owens LM; Rahman A; Manocha P; Al Kassem H; Tahhan AS; Hammadah M; Rosenthal H -
Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD
Volume: 120
11/16/2012 Authors: Li J-M; Yun HD; Waller EK -
Incidence and Geographic Distribution of Adult Acute Lymphoblastic Leukemia in the State of Georgia
Volume: 120
11/16/2012 Authors: El Rassi F; Arellano M; Heffner LT; Waller EK; Winton EF; Ward K; Khoury HJ -
Interleukin-6 Enhances the Survival of Myeloma Cells by Regulating Bim Binding to Anti-Apoptotic Bcl-2 Proteins
Volume: 120
11/16/2012 Authors: Matulis SM; Liu J; Gupta VA; Conage-Pough JE; Nooka AK; Waller EK; Kaufman JL; Lonial S; Boise LH -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Advanced Non Small Cell Lung Cancer Patients with Fewer Numbers of Blood Myeloid Dendritic Cells and CD4 Cells Prior to Treatment Have Inferior Progression-Free Survival: Implications for Cancer Immunotherapy
Volume: 120
11/16/2012 Authors: DeJoubner NJ; Li Q; Harris WAC; Wang Z; Liu Y; Waller EK -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Interleukin-6 Enhances the Survival of Myeloma Cells by Regulating Bim Binding to Anti-Apoptotic Bcl-2 Proteins
Volume: 120
11/16/2012 Authors: Matulis SM; Liu J; Gupta VA; Conage-Pough JE; Nooka AK; Waller EK; Kaufman JL; Lonial S; Boise LH -
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Volume: 120
11/16/2012 Authors: Kozyr N; Ramakrishnan S; Polnett A; Hamby K; Tiwari D; Deane T; Stempora L; Jenkins J; Strobert E; Garcia A -
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood Volume: 120 Page(s): 4256 - 4262
11/15/2012 Authors: Bacher U; Klyuchnikov E; Le-Rademacher J; Carreras J; Armand P; Bishop MR; Bredeson CN; Cairo MS; Fenske TS; Freytes CO -
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
J Immunol Volume: 189 Page(s): 5082 - 5088
11/15/2012 Authors: Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS -
Peripheral-blood stem cells versus bone marrow from unrelated donors.
N Engl J Med Volume: 367 Page(s): 1487 - 1496
10/18/2012 Authors: Anasetti C; Logan BR; Lee SJ; Waller EK; Weisdorf DJ; Wingard JR; Cutler CS; Westervelt P; Woolfrey A; Couban S -
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial.
Bone Marrow Transplant Volume: 47 Page(s): 1350 - 1355
10/01/2012 Authors: Jagasia MH; Abonour R; Long GD; Bolwell BJ; Laport GG; Shore TB; Durrant S; Szer J; Chen M-G; Lizambri R -
Proangiogenic cell colonies grown in vitro from human peripheral blood mononuclear cells.
J Biomol Screen Volume: 17 Page(s): 1128 - 1135
10/01/2012 Authors: Mavromatis K; Sutcliffe DJ; Joseph G; Alexander RW; Waller EK; Quyyumi AA; Taylor WR -
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Biol Blood Marrow Transplant Volume: 18 Page(s): 1287 - 1294
08/01/2012 Authors: Zhang H; Graiser M; Hutcherson DA; Dada MO; McMillan S; Ali Z; Flowers CR; Waller EK -
EVALUATION OF THE SPECTRA OPTIA (R) APHERESIS SYSTEM MONONUCLEAR CELL (MNC) COLLECTION PROCEDURE IN MULTIPLE MYELOMA PATIENTS
VOX SANGUINIS Volume: 103 Page(s): 259 - 260
07/01/2012 Authors: Bill J; Long G; Waller E; Gregurek S; Tricot G -
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.
Biol Blood Marrow Transplant Volume: 18 Page(s): 937 - 943
06/01/2012 Authors: Weisdorf D; Cooley S; Devine S; Fehniger TA; DiPersio J; Anasetti C; Waller EK; Porter D; Farag S; Drobyski W -
Prognostic impact of circulating endothelial cell counts in patients with advanced non-small cell lung cancer
Volume: 30
05/20/2012 Authors: DeJoubner NJ; Kang H; Li Q; Harris WAC; Stewart R; Price A; Quyyumi A; Kono SA; Ramalingam SS; Owonikoko TK -
A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies.
Volume: 30
05/20/2012 Authors: Owonikoko TK; Harvey RD; Kauh JS; Lewis CM; Hossain MS; Akintayo AO; Merriewether AR; Chen Z; Hawk NN; Saba NF -
Translational applications of flow cytometry in clinical practice.
J Immunol Volume: 188 Page(s): 4715 - 4719
05/15/2012 Authors: Jaye DL; Bray RA; Gebel HM; Harris WAC; Waller EK -
Plasmacytoid dendritic cell enrichment of bone marrow allografts enhances GvL activity by facilitating donor T cell engraftment and Th1 polarization
Volume: 188
05/01/2012 Authors: Darlak K; Wang Y; Waller E -
CD28-Directed Costimulation Blockade with Abatacept To Prevent GvHD during High-Risk Unrelated BMT: A First-in-Disease Trial
Volume: 12 Page(s): 34 - 34
05/01/2012 Authors: Kean L; Tiwari D; Mehta A; Sen S; Robertson J; Carr J; Renfroe H; Langston A; Waller E; Horan J -
Grade III-IV acute GvHD and treatment-related mortality are reduced among recipients of larger numbers of donor naive CD8+T-cells and plasmacytoid dendritic cell precursors in allogeneic BM grafts from unrelated donors: results from BMT CTN 0201
Volume: 47 Page(s): S20 - S20
04/01/2012 Authors: Waller E; Harris W; Devine S; Porter D; Ferrara J; McCarty J; Gonzalez C; Spitzer T; Krijanovski O; Howard A -
CD28-DIRECTED T CELL COSTIMULATION BLOCKADE WITH ABATACEPT TO PREVENT GVHD DURING HIGH-RISK UNRELATED HSCT: A FIRST-IN-DISEASE TRIAL
Volume: 18 Page(s): S365 - S365
02/01/2012 Authors: Kean LS; Langston A; Qayed M; Khoury J; Tiwari D; Couture C; Renfroe H; Sen S; Robertson I; Waller EK -
BI-MODAL AGE DISTRIBUTION OF PATIENTS WITH RELAPSED HODGKIN LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION CORRELATES WITH MARKEDLY INFERIOR SURVIVAL AMONG PATIENTS AGE 35 YEARS AND OLDER
Volume: 18 Page(s): S296 - S296
02/01/2012 Authors: Sharma A; Duan M; Chowdhury R; Graiser M; Zhang H; Langston A; Lonial S; Flowers CR; Haight A; Waller EK -
Recovery and rebound of platelet counts in mice after thrombocytopenia induced by combination bortezomib + romidepsin.
Exp Hematol Volume: 40 Page(s): 95 - 96
02/01/2012 Authors: Giver CR; Jaye DL; Waller EK; Lonial S -
DOSE PRECISION USING A PRETRANSPLANT TEST PK OF INTRAVENOUS BUSULFAN PRIOR TO BuCyVP-16 PREPARATIVE REGIMEN IN LYMPHOMA
Volume: 18 Page(s): S246 - S246
02/01/2012 Authors: Lill M; Lim S; Yeh RF; Waller E; Costa LJ; Shore T; Craig M; Freytes CO; Shea TC; Mineishi S -
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon- licensing.
Cytotherapy Volume: 14 Page(s): 147 - 152
02/01/2012 Authors: Franois M; Copland IB; Yuan S; Romieu-Mourez R; Waller EK; Galipeau J -
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
Biol Blood Marrow Transplant Volume: 18 Page(s): 280 - 288
02/01/2012 Authors: Armand P; Kim HT; Zhang M-J; Perez WS; Dal Cin PS; Klumpp TR; Waller EK; Litzow MR; Liesveld JL; Lazarus HM -
IFN- and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
Blood Volume: 119 Page(s): 1075 - 1085
01/26/2012 Authors: Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK -
The regulation and activity of interleukin-12.
Front Biosci (Schol Ed) Volume: 4 Page(s): 888 - 899
01/01/2012 Authors: Wang Y; Fan KT; Li J-M; Waller EK -
Hematopoietic Progenitor Cell Apheresis processing.
Methods Mol Biol Volume: 904 Page(s): 97 - 109
01/01/2012 Authors: Hamilton ES; Waller EK -
Monitoring blood for CD34+ cells to determine timing of Hematopoietic Progenitor Cells Apheresis.
Methods Mol Biol Volume: 904 Page(s): 79 - 83
01/01/2012 Authors: Vaughn ML; Waller EK -
Natural suppressor cells; past, present and future.
Front Biosci (Elite Ed) Volume: 4 Page(s): 1237 - 1245
01/01/2012 Authors: Forghani P; Khorramizadeh MR; Waller EK -
Flagellin, a TLR5 Agonist, Reduces GvHD in Allogeneic HSCT Recipients While Enhancing Anti-Viral Immunity: A Novel Therapeutic Approach
Volume: 118 Page(s): 69 - 69
11/18/2011 Authors: Hossain MS; Jaye DL; Pollack BP; Farr AB; Roback J; Gewirtz AT; Waller EK -
Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients >= 55 Years
Volume: 118 Page(s): 465 - 465
11/18/2011 Authors: McClune B; Pedersen TL; Ahn KW; Warlick ED; Pidala J; Waller EK; Rizzo JD; Cairo MS; Woolfrey A; Artz A -
Equivalent Survival Following Fludarabine/Melphalan Reduced Intensity Conditioning with or without Rabbit ATG As Part of GvHD Prophylaxis
Volume: 118 Page(s): 855 - 856
11/18/2011 Authors: Prichard JM; Muppidi S; Flowers CR; Kaufman JL; Lechowicz MJ; Lonial S; Nooka AK; Sinha R; Waller EK; Langston A -
Temporal Changes in Plerixafor Administration Do Not Impact Hematopoietic Stem Cell Mobilization Efficacy: Results of a Prospective Clinical Trial
Volume: 118 Page(s): 1287 - 1288
11/18/2011 Authors: Harvey RD; Lonial S; Renfroe H; Sinha R; Flowers CR; Lechowicz MJ; Khoury HJ; Langston A; Waller EK; Kaufman JL -
Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)
Volume: 118 Page(s): 707 - 708
11/18/2011 Authors: Sinha R; King N; Shenoy PJ; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman JL; Heffner LT -
Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
Volume: 118 Page(s): 899 - 900
11/18/2011 Authors: Li J; Deppa JA; Ali Z; Graiser M; Langston A; Gleason C; Thomas J; Waller EK -
Blocking Vasoactive Intestinal Peptide Signaling Enhances Anti-Viral Immunity without Increased Graft Versus Host Disease in Murine Allogeneic Bone Marrow Transplantation
Volume: 118 Page(s): 458 - 458
11/18/2011 Authors: Li J-M; Wang Y; Darlak K; Southerland LT; Hossain MS; Giver CR; Waschek JA; Waller EK -
CD28-Directed T Cell Costimulation Blockade with Abatacept to Prevent GvHD During High-Risk Unrelated HSCT: A First-in-Disease Feasibility Trial
Volume: 118 Page(s): 1741 - 1742
11/18/2011 Authors: Kean LS; Langston A; Qayad M; Khoury HJ; Tiwari D; Couture C; Renfroe H; Sen S; Robertson J; Waller EK -
Lack of Host Bone Marrow-Derived Interleukin-12 Increased the Incidence of Allograft Rejection in Allogeneic Bone Marrow Transplantation
Volume: 118 Page(s): 1277 - 1277
11/18/2011 Authors: Wang Y; Li J-M; Harris WAC; Giver CR; Waller EK -
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
J Immunol Volume: 187 Page(s): 5130 - 5140
11/15/2011 Authors: Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK -
Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction.
J Nucl Cardiol Volume: 18 Page(s): 912 - 919
10/01/2011 Authors: Murrow J; Esteves F; Galt J; Chen J; Garcia E; Lin J; Lerakis S; Sher S; Khan Pohlel F; Waller EK -
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Transfusion Volume: 51 Page(s): 2175 - 2182
10/01/2011 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C -
NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.
Blood Volume: 118 Page(s): 2784 - 2792
09/08/2011 Authors: Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Weisdorf DJ; Miller JS -
Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function.
Am J Transplant Volume: 11 Page(s): 1825 - 1834
09/01/2011 Authors: Desmarets M; Mylvaganam G; Waller EK; Josephson CD; Pack C; Lukacher AE; Zimring JC -
Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report.
J Med Case Rep Volume: 5 Page(s): 372
08/12/2011 Authors: Rauf M; Gleason C; Nooka AK; Husman A; Waller EK -
A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation.
Transfusion Volume: 51 Page(s): 1779 - 1783
08/01/2011 Authors: Renfroe H; Arnold M; Vaughn L; Harvey RD; Hamilton E; Lonial S; Khoury HJ; Kaufman JL; Lechowicz MJ; Flowers CR -
Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
J Immunol Volume: 187 Page(s): 1057 - 1065
07/15/2011 Authors: Li J-M; Southerland L; Hossain MS; Giver CR; Wang Y; Darlak K; Harris W; Waschek J; Waller EK -
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Biol Blood Marrow Transplant Volume: 17 Page(s): 1018 - 1024
07/01/2011 Authors: Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang K-Y; Frangoul H; Gale RP; Gee A -
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Blood Volume: 117 Page(s): 6963 - 6970
06/23/2011 Authors: Soiffer RJ; Lerademacher J; Ho V; Kan F; Artz A; Champlin RE; Devine S; Isola L; Lazarus HM; Marks DI -
Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer.
J Clin Oncol Volume: 29 Page(s): 5585
05/20/2011 Authors: Hossain S; Bhimani C; Chen Z; Ramalingam SS; Shin DM; Cohen C; Khuri FR; Waller E; Owonikoko TK -
Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer.
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Hossain S; Bhimani C; Chen Z; Ramalingam SS; Shin DM; Cohen C; Khuri FR; Waller E; Owonikoko TK -
No apparent contribution of HLA-DPA1 to the significantly increased risk for non-relapse mortality associated with non-permissive donor-recipient HLA-DPB1 T cell epitope disparities in unrelated stem cell transplants facilitated through the National Marrow Donor Program
Volume: 77 Page(s): 397 - 398
05/01/2011 Authors: Fleischhauer K; Wang T; Spellman SR; Crivello P; Haagenson M; Battiwalla M; Baxter-Lowe LA; Dehn JW; Gajewski JL; Hale GA -
One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.
Biol Blood Marrow Transplant Volume: 17 Page(s): 640 - 648
05/01/2011 Authors: Valcrcel D; Sierra J; Wang T; Kan F; Gupta V; Hale GA; Marks DI; McCarthy PL; Oudshoorn M; Petersdorf EW -
Non-permissive HLA-DPB1 T-cell epitope disparities are associated with non-relapse mortality after unrelated stem cell transplantation and are not dependent on HLA-DPA1
Volume: 46 Page(s): S74 - S74
04/01/2011 Authors: Fleischhauer K; Spellman SR; Wang T; Haagenson M; Battiwalla M; Baxter-Lowe LA; Dehn JW; Gajewski JL; Hale GA; Heemskerk MB -
Biomarkers of immune activation to screen for severe, acute GVHD.
Bone Marrow Transplant Volume: 46 Page(s): 601 - 604
04/01/2011 Authors: August KJ; Chiang K-Y; Bostick RM; Flanders WD; Waller EK; Langston A; Worthington-White D; Rowland P; Moore KF; Khoury HJ -
Antagonism of vasoactive intestinal peptide activity stimulates anti-viral immunity and protects transplant recipients from murine cytomegalovirus infection
Volume: 46 Page(s): S207 - S207
04/01/2011 Authors: Waller E; Li J-M; Wang Y; Hossain M -
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
Transfus Med Rev Volume: 25 Page(s): 125 - 132
04/01/2011 Authors: Josephson CD; Castillejo M-I; Caliendo AM; Waller EK; Zimring J; Easley KA; Kutner M; Hillyer CD; Roback JD -
Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes.
Leukemia Volume: 25 Page(s): 362 - 365
02/01/2011 Authors: Giver CR; Jaye DL; Waller EK; Kaufman JL; Lonial S -
FLAGELLIN REDUCES GVHD THROUGH EARLY IMMUNOSUPPRESSION INDUCED BY THE FLAGELLIN-TLR5 IMMUNE INTERACTION OF HOST CELLS IN ALLOGENEIC HSCT RECIPIENTS
Volume: 17 Page(s): S303 - S303
02/01/2011 Authors: Hossain MS; Gewirtz AT; Roback JD; Waller EK -
CELLULAR ANTI-VIRAL IMMUNE RESPONSES ARE INCREASED IN THE ABSENCE OF VASOACTIVE INTESTINAL PEPTIDE
Volume: 17 Page(s): S154 - S154
02/01/2011 Authors: Li J-M; Hossain SM; Wang Y; Fan K; Harris W; Waschek J; Waller EK -
A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease.
Cell Transplant Volume: 20 Page(s): 1431 - 1443
01/01/2011 Authors: Bouchentouf M; Forner K; Cuerquis J; Boulassel MR; Routy JP; Waller EK; Quyyumi AA; Paradis P; Schiffrin EL; Galipeau J -
CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.
Am Heart J Volume: 161 Page(s): 98 - 105
01/01/2011 Authors: Quyyumi AA; Waller EK; Murrow J; Esteves F; Galt J; Oshinski J; Lerakis S; Sher S; Vaughan D; Perin E -
Circulating Progenitor Cell Enriched Populations are Predictors of Coronary Artery Disease Burden and Adverse Long Term Outcomes
CIRCULATION Volume: 122
11/23/2010 Authors: Patel RS; Rahman A; Li Q; Neeland IJ; Janjua AU; Murrow J; Rosenthal H; Harris W; Rab ST; Morris D -
Cost-Effectiveness Analysis of a "Just-In-Time" Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant.
Volume: 116 Page(s): 923 - 924
11/19/2010 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Repfroe H; Kaufman JL; Lonial S; Flowers CR; Lechowicz MJ; Langston A -
Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Volume: 116 Page(s): 584 - 584
11/19/2010 Authors: Zhang H; Graiser M; Hutcherson D; Dada MO; McMillan S; Zahir A; Flowers CR; Waller E -
Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignanciesimpact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies
Volume: 116 Page(s): 951 - 952
11/19/2010 Authors: Soiffer RJ; LeRademacher J; Ho VT; Kan F; Artz A; Champlin R; Devine S; Lazarus HM; Marks DI; Porter D -
Paradoxical Immunological Activity of Flagellin: A Novel Method to Reduce GvHD In Allogeneic HSCT Recipients
Volume: 116 Page(s): 627 - 627
11/19/2010 Authors: Hossain MS; Gewirtz AT; Roback J; Waller E -
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Transfusion Volume: 50 Page(s): 2424 - 2431
11/01/2010 Authors: Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ -
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Clin Cancer Res Volume: 16 Page(s): 5079 - 5086
10/15/2010 Authors: Lonial S; Kaufman J; Tighiouart M; Nooka A; Langston AA; Heffner LT; Torre C; McMillan S; Renfroe H; Harvey RD -
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.
Blood Volume: 116 Page(s): 1839 - 1848
09/16/2010 Authors: Gupta V; Tallman MS; He W; Logan BR; Copelan E; Gale RP; Khoury HJ; Klumpp T; Koreth J; Lazarus HM -
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.
Leuk Lymphoma Volume: 51 Page(s): 1473 - 1477
08/01/2010 Authors: Tran H; Arellano M; Chamsuddin A; Flowers C; Heffner LT; Langston A; Lechowicz MJ; Tindol A; Waller E; Winton EF -
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
J Clin Oncol Volume: 28 Page(s): 1878 - 1887
04/10/2010 Authors: McClune BL; Weisdorf DJ; Pedersen TL; Tunes da Silva G; Tallman MS; Sierra J; Dipersio J; Keating A; Gale RP; George B -
Rosiglitazone inhibits breast cancer growth and proliferation via cyclin D1 inhibition
Volume: 70
04/01/2010 Authors: Oberlick E; Taliaferro-Smith LD; Harris W; Knight BB; Nagalingam A; Waller E; Sharma D -
Prophylactic use of flagellin to reduce Graft-vs-Host Disease in allogeneic HSCT recipients: a novel therapeutic approach
Volume: 184
04/01/2010 Authors: Hossain M; Gewirtz A; Roback J; Waller E -
Prochymal (R) improves response rates in patients with steroid-refractory acute graft-versus-host disease involving the liver and gut: results of a randomized, placebo-controlled, multicentre phase III trial in GvHD
Volume: 45 Page(s): S17 - S17
03/01/2010 Authors: Martin PJ; Uberti JP; Soiffer RJ; Klingemann H; Waller EK; Daly A; Herrmann RP; Visani G; Bernardo ME; Schwerdtfeger R -
Donor plasmacytoid dendritic cells activate donor T-cells and augment GvL in allogeneic BMT while limiting GvHD through the generation of T-reg
Volume: 45 Page(s): S2 - S3
03/01/2010 Authors: Waller EK; Lu Y; Li JM -
THE ABSENCE OF VASOACTIVE INTESTINAL PEPTIDE AUGMENTS ALLOREACTIVITY AND THE ANTI-VIRAL RESPONSE IN A BONE MARROW TRANSPLANT SETTING
Volume: 16 Page(s): S223 - S224
02/01/2010 Authors: Li J-M; Shin K; Southerland L; Hossain S; Harris W; Waschek J; Waller EK -
FLAGELLIN-TLR5 IMMUNE RESPONSE: A NOVEL MECHANISM TO REDUCE GVHD IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Volume: 16 Page(s): S160 - S160
02/01/2010 Authors: Hossain MS; Gewirtz AT; Roback JD; Waller EK -
Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation.
J Immunol Volume: 183 Page(s): 7799 - 7809
12/15/2009 Authors: Li J-M; Southerland LT; Lu Y; Darlak KA; Giver CR; McMillin DW; Harris WAC; Jaye DL; Waller EK -
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.
J Clin Invest Volume: 119 Page(s): 3774 - 3786
12/01/2009 Authors: Valenzuela JO; Iclozan C; Hossain MS; Prlic M; Hopewell E; Bronk CC; Wang J; Celis E; Engelman RW; Blazar BR -
Donor Dendritic Cells Home to Lymphoid Organs in Allogeneic Transplant Recipients, Enhance Donor T-Cell Chimerism, and Polarize Donor T-Cell Activation
Volume: 114 Page(s): 31 - 31
11/20/2009 Authors: Fan KT; Li J-M; Lu Y; Harris W; Darlak KA; Forghani P; Shin K; Huang C; Waller EK -
Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD.
Volume: 114 Page(s): 1381 - 1381
11/20/2009 Authors: Hossain MS; Gewirtz AT; Roback JD; Waller EK -
Donor BM Dendritic Cells Expressing IDO Limit Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplant
Volume: 114 Page(s): 544 - 545
11/20/2009 Authors: Lu Y; Harris W; Li J-M; Waller EK -
Targeting PKCtheta Inhibits Afforeactivity and Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia and Anti-Infection Activities.
Volume: 114 Page(s): 969 - 969
11/20/2009 Authors: Yu X-Z; Valenzuela J; Iclozan C; Hossain M; Hopewell E; Bronk C; Wang J; Celis E; Engelman R; Waller EK -
Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.
Volume: 114 Page(s): 478 - 479
11/20/2009 Authors: Hossain MS; Harris WA; Myers SW; Akhtari M; Langston AA; Waller EK -
Mechanical Dyssynchrony Measured by Gated Single Photon Emission Computed Tomography Phase Analysis Predicts Ventricular Remodeling After Acute ST-Elevation Myocardial Infarction
Volume: 120 Page(s): S349 - S349
11/03/2009 Authors: Murrow J; Esteves F; Galt J; Chen J; Garcia E; Lerakis S; Sher S; Waller E; Vaughn D; Perin E -
Dichotomous role of interferon-gamma in allogeneic bone marrow transplant.
Biol Blood Marrow Transplant Volume: 15 Page(s): 1347 - 1353
11/01/2009 Authors: Lu Y; Waller EK -
Howell-Jolly body-like inclusions in neutrophils.
Blood Volume: 114 Page(s): 2860
10/01/2009 Authors: Akhtari M; Waller EK -
Autoimmune neutropenia in adults.
Autoimmun Rev Volume: 9 Page(s): 62 - 66
09/01/2009 Authors: Akhtari M; Curtis B; Waller EK -
Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.
Am Heart J Volume: 158 Page(s): 53 - 60.e1
07/01/2009 Authors: Subramaniyam V; Waller EK; Murrow JR; Manatunga A; Lonial S; Kasirajan K; Sutcliffe D; Harris W; Taylor WR; Alexander RW -
Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Immunotherapy Volume: 1 Page(s): 599 - 621
07/01/2009 Authors: Li J-M; Giver CR; Lu Y; Hossain MS; Akhtari M; Waller EK -
The HDAC inhibitor panobinostat (LBH589) induces transient thrombocytopenia in mice, with minimal effects on bone marrow megakaryocyte populations
Volume: 69
05/01/2009 Authors: Giver C; Waller E; Lonial S -
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody).
J Immunother Volume: 32 Page(s): 322 - 324
04/01/2009 Authors: Akhtari M; Waller EK; Jaye DL; Lawson DH; Ibrahim R; Papadopoulos NE; Arellano ML -
CD34+Cell Infusion after ST Elevation Myocardial Infarction is Associated with Improved Perfusion
Volume: 53 Page(s): A327 - A327
03/10/2009 Authors: Quyyumi AA; Murrow JR; Esteves F; Galt J; Oshinski J; Lerakis S; Sher S; Pohlel K; Waller EK; Vaughn D -
Howell-Jolly bodies in patients with chronic GVHD.
Blood Volume: 113 Page(s): 2125
03/05/2009 Authors: Akhtari M; Waller EK -
FLAGELLIN, A TLR5 AGONIST, FACILITATES PRODUCTION OF FOXP3+CD4+CD25+REGULATORY T CELLS TO MAINTAIN BALANCED IMMUNE RECONSTITUTION IN ALLOGENEIC BMT WITHOUT GVHD
Volume: 15 Page(s): 12 - 12
02/01/2009 Authors: Hossain MS; Roback JD; Gewirtz AT; Waller EK -
INTERACTIONS BETWEEN DC AND T-CELLS INITIATE COUNTER-REGULATORY IMMUNE ACTIVITIES THAT LIMITS AMPLIFICATION OF ALLO-IMMUNE RESPONSES AND GvHD
Volume: 15 Page(s): 124 - 124
02/01/2009 Authors: Lu Y; Li J-M; Harris W; Waller E -
A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma
CLINICAL LYMPHOMA & MYELOMA Volume: 9 Page(s): S60 - S60
02/01/2009 Authors: Kaufman JL; Lonial S; Sinha R; Torre C; Langston AA; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT -
EXTRACORPOREAL PHOTOPHERESIS THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE: RESPONSE IS ASSOCIATED WITH CONTENT OF DENDRITIC CELLS AND T-CELLS IN PERIPHERAL BLOOD AT INITIATION OF TREATMENT
Volume: 15 Page(s): 128 - 129
02/01/2009 Authors: Akhtari M; Giver CR; Renfroe HM; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL -
PHARMACOKINETIC (PK) COMPARISON OF INTRAVENOUS VERSUS ORAL BUSULFAN CONDITIONING REGIMENS FOR ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) PATIENTS
Volume: 15 Page(s): 154 - 155
02/01/2009 Authors: Hutcherson DA; Surati M; Sanvidge K; Harvey D; Al-Baldawi RN; Langston A; Flowers C; Lonial S; Kaufman J; Lechowicz MJ -
DONOR DENDRITIC CELLS INITIATE COUNTER-REGULATORY IMMUNE RESPONSES AND GVL EFFECTS IN ALLLOGENEIC BMT
Volume: 15 Page(s): 119 - 119
02/01/2009 Authors: Li J-M; Darlak KA; Lu Y; Harris W; Jaye DL; Waller EK -
Activation of EGFR signaling in CD44 positive cells promotes aggressive behavior and progression of breast cancer
Volume: 69 Page(s): 317S - 317S
01/15/2009 Authors: Karna P; Cao Z; Oprea G; Cohen C; Harris W; Waller EK; O'Regan R; Wood WC; Yang L -
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients.
Bone Marrow Transplant Volume: 43 Page(s): 155 - 158
01/01/2009 Authors: Akhtari M; Langston AA; Waller EK; Gal AA -
Phase I Dose-Escalation Trial of BI 2536, a Polo-Like Kinase 1 Inhibitor, in Relapsed and Refractory Non-Hodgkin's Lymphoma
Volume: 112 Page(s): 93 - 93
11/16/2008 Authors: Vose JM; Young A; Friedberg JW; Waller EK; Cheson BD; Tromnieshauser D; Munzert G -
Patulin Acts Synergistically with Doxorubicin and Bortezomib in Cytotoxicity against Hematological Malignancies.
Volume: 112 Page(s): 921 - 921
11/16/2008 Authors: Hessel A; Tselanyane M; Wang F; David E; Lonial S; Waller EK -
Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study
Volume: 112 Page(s): 1247 - 1247
11/16/2008 Authors: Langston AA; Murali S; McMillan S; Heffner LT; Lonial S; Waller EK; Flowers CR; Kaufman J; McLemore ML; Sinha R -
Flagellin, a TLR5 Agonist, Down-Regulate CD62L on Donor T Cells and Limit GvHD in Allogeneic Hematopoietic Stem Cell Transplantation
Volume: 112 Page(s): 1207 - 1207
11/16/2008 Authors: Hossain M; Gewirtz AT; Roback JD; Waller EK -
Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease
Volume: 112 Page(s): 432 - 432
11/16/2008 Authors: Giver CR; Akhtari M; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL; Vaughn ML -
A Randomized Phase I Trial of Melphalan plus Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration
Volume: 112 Page(s): 1144 - 1145
11/16/2008 Authors: Lonial S; Kaufman J; Torre C; Langston A; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT; Waller EK -
Paradoxical Effects of Interferon-gamma in Allogeneic Bone Marrow Transplant: Donor Dendritic Cells Regulate Graft-Versus-Leukemia and Graft-Versus-Host Disease Activities
Volume: 112 Page(s): 816 - 816
11/16/2008 Authors: Lu Y; Li J-M; Harris W; Waller E -
Donor dendritic cells dance the do-si-do in allogeneic transplantation.
Blood Volume: 112 Page(s): 3007 - 3008
10/15/2008 Authors: Waller EK; Li J-M -
Circulating Progenitor Cell Levels are Decreased in Patients with Diabetes after Coronary Stenting
Volume: 102 Page(s): 107I - 107I
10/12/2008 Authors: Ghasemzadeh N; Forghani Z; Hameed S; Waller EK; Taylor WR; Quyyumi A; Mavromatis K -
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
Bone Marrow Transplant Volume: 42 Page(s): 529 - 534
10/01/2008 Authors: Murali S; Winton E; Waller EK; Heffner LT; Lonial S; Flowers C; Kaufman J; Arellano M; Lechowicz MJ; Mann KP -
Regulation of alloimmune responses by dendritic cell subsets.
Exp Hematol Volume: 36 Page(s): 1309 - 1317
10/01/2008 Authors: Lonial S; Torre C; David E; Harris W; Arellano M; Waller EK -
Therapeutic use of flagellin to prevent graft-vs-host disease and improve viral immunity following allogeneic transplant
Volume: 48 Page(s): 9A - 10A
09/01/2008 Authors: Hossain M; Gewirtz A; Hillyer C; Waller E; Roback JD -
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Blood Volume: 112 Page(s): 426 - 434
07/15/2008 Authors: Marks DI; Prez WS; He W; Zhang M-J; Bishop MR; Bolwell BJ; Bredeson CN; Copelan EA; Gale RP; Gupta V -
Patients with diabetes have reduced circulating CD34+cells after coronary stenting
Volume: 28 Page(s): E77 - E77
06/01/2008 Authors: Mavromatis K; Ghasemzadeh N; Forghani Z; Hameed S; Waller EK; Quyyumi AA; Taylor WR -
Research participants' views of nontherapeutic biopsies
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Pentz RD; Xu Z; Lonial S; Kauh JS; O'Regan RM; Waller EK; Shin DM; Fu H; Khuri F -
The prognostic significance of donor dendritic cells in allogeneic hematopoietic progenitor cell transplant
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Dejoubner N; Ali Z; Grasier M; Hamilton E; Flowers C; Lonial S; Langston A; Waller EK -
Induction of GvL after allogeneic stem cell transplantation
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Arellano ML; Harris W; Langston A; McMillan S; Rosenthal H; Waller EK -
Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection.
J Immunol Volume: 180 Page(s): 6892 - 6902
05/15/2008 Authors: Hossain MS; Roback JD; Wang F; Waller EK -
EGFR signal activated HIF-1 alpha/survivin pathway confers apoptosis resistance in CD 44+breast cancer stem cells
Volume: 68
05/01/2008 Authors: Karna P; Cao Z; Harris W; Oprea G; O'Reagan R; Waller E; Wood W; Yang L -
Double allogeneic haematopoietic cell transplant in a murine BMT model supports a stochastic model for engraftment
Volume: 41 Page(s): S329 - S329
03/01/2008 Authors: Darlak KA; Li JM; Waller AF; Wang F; Waller EK -
EOSINOPHILIC PULMONARY SYNDROME AS A MANIFESTATION OF PULMONARY GRAFT-VERSUS-HOST-DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THREE PATIENTS
Volume: 14 Page(s): 141 - 141
02/01/2008 Authors: Akhtari M; Lanston A; Waller E; Gal A -
EARLY DETECTION OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE USING PLASMA MARKERS OF T-CELL ACTIVATION
Volume: 14 Page(s): 133 - 133
02/01/2008 Authors: August KJ; Chiang K-J; Bostick RM; Waller EK; Langston A; Khoury HJ; Moore KF; Worthington-White D; Rowland P; Horan JT -
Allogeneic Transplantation for Multiple Myeloma
Page(s): 125 - 142
01/01/2008 Authors: Wang F; Waller EK -
Bone marrow derived CD34(+)CXCR4(+) cells maintain viability, mobility and sterility up to 72 hours and are compatible with balloon dilatation catheters used for intra coronary artery infusion; Pre-clinical development of a pharmaceutical grade cell therapy for acute myocardial infarction (AMR-001)
Volume: 110 Page(s): 368A - 368A
11/16/2007 Authors: Pecora AL; Preti RA; Chan WS; Waller EK; Quyyumi A; Vaughan D; Moss T -
The absence of vasoactive intestinal peptide augments allo-reactivity and the anti-viral response in bone marrow transplantation
Volume: 110 Page(s): 959A - 959A
11/16/2007 Authors: Southerland LT; Li J-M; Hossain S; Giver C; Harris W; Waschek J; Waller EK -
Hemorrhagic cystitis after hematopoietic stem cell trans-plantation: much progress and many remaining issues.
Chin Med J (Engl) Volume: 120 Page(s): 1671
10/05/2007 Authors: Waller EK -
Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
Biol Blood Marrow Transplant Volume: 13 Page(s): 895 - 904
08/01/2007 Authors: Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK -
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Biol Blood Marrow Transplant Volume: 13 Page(s): 844 - 852
07/01/2007 Authors: Giralt S; Logan B; Rizzo D; Zhang M-J; Ballen K; Emmanouilides C; Nath R; Parker P; Porter D; Sandmaier B -
The occurrence of idiopathic secondary post-transplant thrombocytopenia and the kinetics of platelet recovery predict survival in patients undergoing autologous hematopoietic progenitor cell transplantation
Volume: 25
06/20/2007 Authors: Waller E; Ninan MJ; Roback J; Arellano M; Flowers C -
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 746 - 747
06/01/2007 Authors: Santos EC; Sessions J; Hutcherson D; Flowers C; Langston A; Waller EK -
Bortezomib,thalidomide and dexamethasone as induction
Volume: 92 Page(s): 181 - 181
06/01/2007 Authors: Kaufman JL; Gleason C; Heffner LT; Langston AA; Waller EK; Lonial S -
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
Blood Volume: 109 Page(s): 4548 - 4556
05/15/2007 Authors: Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. (vol 47, pg 629, 2007)
TRANSFUSION Volume: 47 Page(s): 952 - 952
05/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi SS; Teagarden D; Hamilton ES; Waller EK -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Transfusion Volume: 47 Page(s): 629 - 635
04/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK -
CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
J Clin Oncol Volume: 25 Page(s): 1288
04/01/2007 Authors: Hammond AL; Waller EK; Finkelstein LB -
Chronic GVHD decreases anti-cmv immune responses in allogeneic BMT: Defect in T-cell homing
Volume: 13 Page(s): 126 - 126
02/01/2007 Authors: Hossain MS; Roback JD; Pollack BP; Jaye DL; Waller EK -
A randomized phase I trial of melphalan plus bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administration
Volume: 13 Page(s): 56 - 56
02/01/2007 Authors: Lonial S; Kaufman J; Langston AA; Khoury HJ; Torre C; Lechowicz MJ; Flowers C; Waller EK -
The allo-reactivity of donor T-cells is shaped by the presence of immunostimulatory or immunosuppressive donor dendritic cell subsets in the graft: Implications for GVHD and GVL in BMT
Volume: 13 Page(s): 16 - 16
02/01/2007 Authors: Southerland LT; Li J. M; Waller EK -
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 116 - 123
01/01/2007 Authors: Arellano ML; Langston A; Winton E; Flowers CR; Waller EK -
The yin and yang of adaptive immunity in allogeneic hematopoietic cell transplantation: donor antigen-presenting cells can either augment or inhibit donor T cell alloreactivity.
Adv Exp Med Biol Volume: 590 Page(s): 69 - 87
01/01/2007 Authors: Li J-M; Waller EK -
The role of sargramostim (rhGM-CSF) as immunotherapy.
Oncologist Volume: 12 Suppl 2 Page(s): 22 - 26
01/01/2007 Authors: Waller EK -
Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Mod Pathol Volume: 19 Page(s): 1555 - 1562
12/01/2006 Authors: Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D -
Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant Volume: 12 Page(s): 1239 - 1249
12/01/2006 Authors: Li J-M; Gorechlad J; Larsen CP; Waller EK -
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Leuk Lymphoma Volume: 47 Page(s): 2155 - 2162
10/01/2006 Authors: Lonial S; Arellano M; Hutcherson D; Langston A; Flowers C; Heffner LT; Winton E; Jo Lechowicz M; Waller EK -
Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.
Exp Hematol Volume: 34 Page(s): 895 - 904
07/01/2006 Authors: Li J-M; Giver CR; Waller EK -
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Cancer Volume: 106 Page(s): 2171 - 2180
05/15/2006 Authors: Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S -
Stimulation of endothelial progenitor cells with granulocyte macrophage colony stimulating factor improves endothelial dysfunction in patients with peripheral arterial disease
Volume: 47 Page(s): 382A - 383A
02/21/2006 Authors: Subramaniyam V; Reddy U; Sutcliffe D; Harris W; LeFever S; Waller E; Taylor WR; Kolm P; Alexander RW; Quyyumi A -
Antigen specific T-cell response to aspergillus fumigatus in unrelated allogeneic transplant recipients
Volume: 12 Page(s): 41 - 42
02/01/2006 Authors: Rosenthal HS; Somani J; Nolte FS; Waller EK -
Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GvL effects in allogeneic BMT
Volume: 12 Page(s): 63 - 64
02/01/2006 Authors: Li JM; Giver CR; Waller EK -
Receiver operator characteristics of the Sysmex HPC measurement used to initiate apheresis of blood hematopoietic progenitor cells
Volume: 12 Page(s): 10 - 10
02/01/2006 Authors: Hamilton ES; Flowers CR; Vaughn ML; Minerley M; Waller EK -
Idiopathic secondary post-transplant thrombocytopenia (ISPT) following autologous hematopoietic progenitor cell transplantation (HPCT) is associated with transplantation of lower numbers of primitive hematopoietic progenitors
Volume: 12 Page(s): 132 - 132
02/01/2006 Authors: Ninan MJ; Arellano M; Philip A; Langston A; Flowers CR; Lonial S; Kaufman J; Lechowicz M; Khoury JH; Roback J -
Apoptotic donor leukocytes inhibit tolerance and limit mixed chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation
Volume: 12 Page(s): 80 - 80
02/01/2006 Authors: Li JM; Giver CR; Gorechlad J; Larsen CP; Walker EK -
Reduced-intensity conditioning permits a significant graft vs leukemia (GvL) effect for acute leukemia
Volume: 12 Page(s): 69 - 70
02/01/2006 Authors: Arellano M; Flowers C; Waller E; Lonial S; Kaufman J; Winton E; Khoury H; Langston A -
Relapse rates in patients with AML in relation to type of transplant and CD56 positivity
Volume: 86 Page(s): 248A - 248A
01/01/2006 Authors: Taylor K; Jaye D; Graiser M; Easley K; Waller E -
Relapse rates in patients with AML in relation to type of transplant and CD56 positivity
Volume: 19 Page(s): 248A - 248A
01/01/2006 Authors: Taylor K; Jaye D; Graiser M; Easley K; Waller E -
The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.
Blood Volume: 106 Page(s): 4322 - 4329
12/15/2005 Authors: David E; Sun S-Y; Waller EK; Chen J; Khuri FR; Lonial S -
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.
Blood Volume: 106 Page(s): 3777 - 3784
12/01/2005 Authors: Lonial S; Waller EK; Richardson PG; Jagannath S; Orlowski RZ; Giver CR; Jaye DL; Francis D; Giusti S; Torre C -
Patient characteristics in CD 20(+) and CD 20(-) adult acute lymphoblastic leukemia (ALL): A single institution analysis.
Volume: 106 Page(s): 210B - 210B
11/16/2005 Authors: Gladney SP; Heffner LT; Langston A; Holden J; Phillips C; Winton E; Flowers CR; Lechowicz MJ; Lonial S; Waller E -
Effects of mycotoxins on mononuclear cells (MNCs) in normal blood, T-cell leukemia and lymphoma cell lines.
Volume: 106 Page(s): 287B - 287B
11/16/2005 Authors: Klein KR; Woodward CS; Waller EK; Lechowicz MJ; Rosenthal H -
Prophylactic amotosalen-treated donor T-cells prevent late CMV infection in allogeneic bone marrow transplantation.
Volume: 106 Page(s): 847A - 847A
11/16/2005 Authors: Hossain MS; Robak JD; Waller EK -
Ex vivo fludarabine selectively depletes human naive T-Cell subsets: A step toward modifying donor lymphocyte infusion.
Volume: 106 Page(s): 312A - 312A
11/16/2005 Authors: Smith MM; Giver CR; Waller EK; Flowers CR -
Relapse free survival of elderly AML patients is comparable to that of younger adults when treated with a modified dose intensive cytarabine regimen.
Volume: 106 Page(s): 237B - 237B
11/16/2005 Authors: Langston AA; Heffner LT; Hutcherson D; Neely J; Flowers C; Waller EK; Lonial S; Khoury HJ; Winton E -
Decreased incidence of relapse in patients with acute leukemia transplanted from matched unrelated donors: Induction of GvL
Volume: 106 Page(s): 570A - 571A
11/16/2005 Authors: Arellano ML; Langston A; Lonial S; Flowers C; Khoury JH; Winton E; Waller EK; Mary LJ -
A randomized trial to evaluate the impact of cytokines (G-CSF or GM plus GCSF) on dendritic cell and T-cell content and function when mobilizing normal donors for allogeneic progenitor cell transplant
Volume: 106 Page(s): 555A - 555A
11/16/2005 Authors: Lonial S; Torre C; Langston AA; McMillans S; Hamilton E; Flowers C; Lechowicz MJ; Waller EK -
Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.
J Virol Volume: 79 Page(s): 10397 - 10407
08/01/2005 Authors: Chahroudi A; Chavan R; Kozyr N; Waller EK; Silvestri G; Feinberg MB -
Dendritic cell-directed cytokines induced a GvL effect in patients with acute leukemia who relapsed after allogeneic transplant
Volume: 33 Page(s): 86 - 86
07/01/2005 Authors: Waller EK; Arellano M -
Bortezomib-associated transient and cyclical thrombocytopenia: evidence for lack of marrow cytotoxicity.
Volume: 23 Page(s): 587S - 587S
06/01/2005 Authors: Lonial S; Waller EK; Richardson PG; Jagannath S; Orlowski RZ; Giver CR; Jaye DL; Barlogie B; Heffner LT; Anderson KC -
Results of a clinical phase I dose-escalation study of cylarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma.
Volume: 23 Page(s): 607S - 607S
06/01/2005 Authors: Arellano ML; Lonial S; Langston A; Flowers C; Heffner T; Hutcherson D; Winton E; Waller E -
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant Volume: 11 Page(s): 169 - 180
03/01/2005 Authors: Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK -
Rituximab does not inhibit chemo-mobilization of HPC or engraftment following autologous transplant for lymphoma
Volume: 11 Page(s): 6 - 6
02/01/2005 Authors: Kaufman JL; Lonial S; Hicks M; Langston A; Flowers C; Lechowicz MJ; Khoury H; Waller EK -
Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue.
J Vasc Res Volume: 42 Page(s): 174 - 180
01/01/2005 Authors: Jabs A; Moncada GA; Nichols CE; Waller EK; Wilcox JN -
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Biol Blood Marrow Transplant Volume: 10 Page(s): 848 - 857
12/01/2004 Authors: Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK -
Predictors of more rapid lymphoid reconstitution after allogeneic transplantation
Volume: 104 Page(s): 864A - 864A
11/16/2004 Authors: Arellano ML; Moore SG; Kudchadkar R; Flowers CR; Langston AA; Lonial S; Lechowicz MJ; Waller EK -
A randomized trial to evaluate the impact of cytokines on dendritic cell, T-cell and T-cell function when mobilizing normal donors for allogeneic progenitor cell transplant: An interim analysis.
Volume: 104 Page(s): 780A - 780A
11/16/2004 Authors: Lonial S; Torre C; Hicks M; Mcmillan S; Langston AA; Flowers CR; Lechowicz MJ; Waller EK -
MCMV infection lowers the threshold for the development of clinical GvHD after allogeneic bone marrow transplantation.
Volume: 104 Page(s): 585A - 585A
11/16/2004 Authors: Hossain MS; Roback JD; Waller EK -
A phase I trial of ara-C, topotecan, and gemtuzumab ozogamicin (Mylotarg (R)) for advanced MDS and secondary or relapsed AML.
Volume: 104 Page(s): 502A - 502A
11/16/2004 Authors: Langston AA; McMillan S; Lonial S; Smith K; Waller EK; Heffner LT; Bucur S; Redei I; Flowers C; Lechowicz MJ -
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Volume: 33 Page(s): 196 - 197
11/01/2004 Authors: Waller E; Giver C; Somani J; Langston A; Lonial S; Roback J; Jian ML; Hossain M; Redei I -
Identification of peptide sequences that selectively bind type 2 dendritic cells and a subset of plasmacytoid dendritic cell-related acute myelogenous leukemia: Implications for immunotherapy
Volume: 27 Page(s): S6 - S7
11/01/2004 Authors: Waller E; Rosenthal H; Taylor K; Li JM; Jaye D -
Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
Curr Hematol Rep Volume: 3 Page(s): 424 - 431
11/01/2004 Authors: Arellano M; K Waller E -
Prophylactic amotosalen-treated splenocytes effectively prevent lethality from delayed murine CMV challenge in allogeneic BMT recipients
Volume: 44 Page(s): 6A - 6A
09/01/2004 Authors: Hossain MS; Lezhava L; Waller EK; Roback JD -
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant Volume: 10 Page(s): 540 - 551
08/01/2004 Authors: Li J-M; Waller EK -
Cellular immunotherapy and cancer.
Semin Oncol Volume: 31 Page(s): 87 - 90
04/01/2004 Authors: Waller EK -
Cellular immunotherapy and cancer
Volume: 31 Page(s): 87 - 90
04/01/2004 Authors: Waller EK -
Donor antigen-presenting cells regulate graft-versus-leukaemia effects after allogeneic transplantation
Volume: 33 Page(s): S18 - S18
03/01/2004 Authors: Waller E; Li J; Lonial S -
Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
Bone Marrow Transplant Volume: 33 Page(s): 543 - 548
03/01/2004 Authors: Miller CB; Waller EK; Klingemann HG; Dignani MC; Anaissie EJ; Cagnoni PJ; McSweeney P; Fleck PR; Fruchtman SM; McGuirk J -
Optimization of chemo-mobilization of autologous blood hematopoietic progenitor cell grafts
Volume: 10 Page(s): 64 - 65
02/01/2004 Authors: Hicks ML; Lonial S; Langston A; Smith KJ; Sai SM; Hamilton ES; Waller EK -
Isolation and functional inhibitory affects of specific peptides bound to type 2 dendritic cells (DC2)
Volume: 10 Page(s): 16 - 17
02/01/2004 Authors: Rosenthal HS; Jaye DL; Cherry E; Waller EK -
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Blood Cells Mol Dis Volume: 33 Page(s): 233 - 237
01/01/2004 Authors: Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li J-M; Hossain MS; Redei I -
Reconstructing immunity after allogeneic transplantation.
Immunol Res Volume: 29 Page(s): 269 - 282
01/01/2004 Authors: Giver CR; Li J-M; Hossain MS; Lonial S; Waller EK -
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
J Immunol Volume: 171 Page(s): 6023 - 6031
12/01/2003 Authors: Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD -
Purified donor CD4 memory T-cells promote immune reconstitution without GvHD in a fully MHC mismatched BMT system.
Volume: 102 Page(s): 701A - 702A
11/16/2003 Authors: Giver CR; Waller EK -
A phase I study of dose escalated cytarabine in combination with a modified ESHAP-like regimen, paclitaxel, and vinorelbine (VTEPA) for the treatment of relapsed/refractory lymphoma.
Volume: 102 Page(s): 293B - 293B
11/16/2003 Authors: Lonial S; Tanner A; Langston AA; Redei I; Heffner LT; Bucur SZ; Hutcherson D; Winton E; Waller EK -
Correlation between T-cell reconstitution and serum IL-7 levels post-hematopoietic progenitor stem cell transplant (HPSCT).
Volume: 102 Page(s): 941A - 942A
11/16/2003 Authors: Radziewicz HT; Sumpter B; Poindexter G; Paiardini M; Cervasi B; Muthukumar A; Sodora DL; Waller EK; Silvestri GG; Somani J -
Adoptive transfer of amotosalen treated donor T cells leads to the polyclonal expansion of anti-CMV memory T cells without GvHD after allogencic bone marrow transplantation.
Volume: 102 Page(s): 702A - 702A
11/16/2003 Authors: Hossain MS; Roback JD; Lezhava L; Hearst JE; Talib S; Waller EK -
Early autologous transplantation for mantle cell lymphoma may improve long term disease-free survival.
Volume: 102 Page(s): 734A - 735A
11/16/2003 Authors: Murali S; Lonial S; Redei I; Smith K; Waller EK; Heffner LT; Bucur S; Winton E; Manion K; Langston A -
Evaluation of the degree of thrombocytopenia and associated risk factors following bortezomib therapy for relapsed multiple myeloma.
Volume: 102 Page(s): 447A - 447A
11/16/2003 Authors: Lonial S; Waller EK; Richardson PG; Jagannath S; Francis D; Lehman M; Torre C; Barlogie B; Berenson JR; Singhal S -
Modulation of allogeneic PBPC graft contents using G-CSF or G-CSF+GM-CSF: Preliminary results from a randomized trial.
Volume: 102 Page(s): 953A - 953A
11/16/2003 Authors: Lonial S; Torre C; Hicks M; Tanner A; Langston AA; Redei I; Waller EK -
Optimal timing for chemotherapy and cytokine mobilization of autologous blood hematopoietic progenitor cells.
Volume: 102 Page(s): 419B - 419B
11/16/2003 Authors: Hicks ML; Lonial S; Langston A; Smith KJ; Sai SM; Hamilton ES; Waller EK -
Safety of voriconazole after autologous and allogeneic stem cell transplantation.
Volume: 102 Page(s): 454B - 454B
11/16/2003 Authors: Restrepo MH; Langston AA; Shayani S; Waller EK; Lonial S -
Bortezomib inhibits T cell proliferation.
Volume: 102 Page(s): 61B - 61B
11/16/2003 Authors: Kaufman JL; Waller EK; Torre C; Boswell MG; Lonial S -
Donor CD11b+ BM cells suppress immune reconstitution, GVL and GVHD in allogeneic BMT.
Volume: 102 Page(s): 410B - 411B
11/16/2003 Authors: Li JM; Waller EK -
A phase I trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg (R)) for advanced MDS and secondary or relapsed AML.
Volume: 102 Page(s): 333B - 333B
11/16/2003 Authors: Langston AA; Tanner A; Lonial S; Heffner LT; Smith K; Bucur S; Waller EK; Redei I; Winton E -
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Biol Blood Marrow Transplant Volume: 9 Page(s): 616 - 632
10/01/2003 Authors: Giver CR; Montes RO; Mittelstaedt S; Li J-M; Jaye DL; Lonial S; Boyer MW; Waller EK -
Long-term functional persistence of amotosalen-treated T-cells after adoptive transfer
Volume: 43 Page(s): 16A - 17A
09/01/2003 Authors: Roback JD; Hossain MS; Lezhava L; Talib S; Hearst JE; Waller EK; Hillyer CD -
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
Biol Blood Marrow Transplant Volume: 9 Page(s): 460 - 471
07/01/2003 Authors: Waller EK; Langston AA; Lonial S; Cherry J; Somani J; Allen AJ; Rosenthal H; Redei I -
Modulation of antitumor immune responses by hematopoietic cytokines.
Cancer Volume: 97 Page(s): 1797 - 1809
04/01/2003 Authors: Waller EK; Ernstoff MS -
Signal transduction and myeloma: new targets, new hope.
Cancer Biol Ther Volume: 2 Page(s): 310 - 319
01/01/2003 Authors: Lonial S; Waller EK; Simons JW; Heffner LT -
A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses.
Vaccine Volume: 21 Page(s): 221 - 230
12/13/2002 Authors: Somani J; Lonial S; Rosenthal H; Resnick S; Kakhniashvili I; Waller EK -
Three methods of T-cell depletion of HPCT products: Analysis of CD34+ cell and lymphocyte purity and recovery.
Volume: 100 Page(s): 835A - 836A
11/16/2002 Authors: Lonial S; Rizzieri DA; Koh LP; Jones M; Langston AA; Redei I; Long GD; Gasparetto C; Vredenburgh JJ; Waller EK -
Effect of donor dendritic cells on overall survival and incidence of GvHD after allogeneic HPCT from HLA matched sibling donors.
Volume: 100 Page(s): 420A - 421A
11/16/2002 Authors: Gladney SP; Waller EK; Redei I; Langston AA; Lonial S -
Indirect antigen presentation is more effective when the responder T-cell population is naive not memory T-cells.
Volume: 100 Page(s): 58B - 59B
11/16/2002 Authors: Lonial S; Torre C; Stuebner M; Waller EK -
Therapy with thalidomide enhances overall survival after autologous PBSC transplant for multiple myeloma.
Volume: 100 Page(s): 178A - 178A
11/16/2002 Authors: Brinker B; Waller EK; Langston AA; Redei I; Smith KJ; Bucur SZ; Winton E; Lyles R; Heffner LT; Lonial S -
Depletion of monocytes and DC2 enhances T-cell proliferation and IL12 production in response to allo-antigen: Implications for allogeneic transplantation.
Volume: 100 Page(s): 615A - 615A
11/16/2002 Authors: Stuebner M; Torre C; Waller EK; Lonial S -
Fludarabine treatment of allogeneic donor lymphocytes selects for Th2 regulatory T-cells and reduces GvHD activity in MHC mis-matched murine BMT.
Volume: 100 Page(s): 824A - 825A
11/16/2002 Authors: Giver CR; Montes RO; Mittelstaedt S; Jaye DL; Lonial S; Li JM; Boyer MW; Waller EK -
Polarization towards Th 1 Anti-mCMV immune responses following depletion of CD11b+ cells from mouse bone marrow.
Volume: 100 Page(s): 399B - 400B
11/16/2002 Authors: Hossain MS; Schnell FJ; Roback JD; Waller EK -
Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia.
Bone Marrow Transplant Volume: 30 Page(s): 687 - 697
11/01/2002 Authors: Jurickova I; Waller EK; Yeager AM; Boyer MW -
Optimized psoralen-mediated DNA crosslinking of CD8+ T-lymphocytes preserves IFN-gamma production while blocking cell proliferation: Implications for adoptive immunotherapy.
Volume: 42 Page(s): 6S - 6S
09/01/2002 Authors: Roback JD; Lezhava L; Hossain MS; Waller EK; Hillyer CD -
Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Bone Marrow Transplant Volume: 30 Page(s): 335 - 340
09/01/2002 Authors: Redei I; Langston AA; Lonial S; Cherry JK; Allen AJ; Hamilton E; Jones M; Bartlett VM; Waller EK -
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
Exp Hematol Volume: 30 Page(s): 1044 - 1050
09/01/2002 Authors: Schuster MW; Beveridge R; Frei-Lahr D; Abboud CN; Cruickshank S; Macri M; Menchaca D; Holden J; Waller EK -
Ex-vivo exposure to fludarabine reduces allo-proliferation and preserves homeostatic proliferation of donor T-cells in MHC mismatched transplants
Volume: 30 Page(s): 86 - 86
06/01/2002 Authors: Giver C; Montes RO; Mittelstaedt S; Lonial S; Li JM; Boyer MW; Waller EK -
Immuno-regulatory role of donour CD11b+cells in allogeneic BMT: effects on immune reconstitution, GVL and GVHD
Volume: 30 Page(s): 87 - 87
06/01/2002 Authors: Li J; Giver CR; Waller EK -
Long-term chimerism from T-cell depleted allogeneic one marrow transplantation with low-dose busulfan and CD40-CD154 blockade
EXPERIMENTAL HEMATOLOGY Volume: 30 Page(s): 118 - 118
06/01/2002 Authors: Li J; Gorechald J; Larsen C; Waller E -
Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model.
Am J Pathol Volume: 160 Page(s): 2145 - 2155
06/01/2002 Authors: Lessner SM; Prado HL; Waller EK; Galis ZS -
Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model
FASEB JOURNAL Volume: 16 Page(s): A218 - A219
03/20/2002 Authors: Lessner S; Prado H; Waller E; Galis Z -
Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell line.
Leuk Lymphoma Volume: 43 Page(s): 631 - 634
03/01/2002 Authors: Shaw RN; Waller EK; Offermann MK -
A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
Blood Volume: 99 Page(s): 1840 - 1849
03/01/2002 Authors: Kean LS; Durham MM; Adams AB; Hsu LL; Perry JR; Dillehay D; Pearson TC; Waller EK; Larsen CP; Archer DR -
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
Blood Volume: 99 Page(s): 1085 - 1088
02/01/2002 Authors: Langston AA; Redei I; Caliendo AM; Somani J; Hutcherson D; Lonial S; Bucur S; Cherry J; Allen A; Waller EK -
DC2 effect on survival following allogeneic bone marrow transplantation.
Oncology (Williston Park) Volume: 16 Page(s): 19 - 26
01/01/2002 Authors: Waller EK; Rosenthal H; Sagar L -
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.
Blood Volume: 98 Page(s): 3205 - 3211
12/01/2001 Authors: Lee SJ; Klein JP; Anasetti C; Antin JH; Loberiza FR; Bolwell BJ; LeMaistre CF; Litzow MR; Marks D; Waller EK -
Infectious outcomes after alternative donor stem cell transplantation: A retrospective cohort study.
BLOOD Volume: 98 Page(s): 205A - 205A
11/16/2001 Authors: Somani J; Redei I; Cherry J; Tanner A; Lonial S; Bartlett V; Manion K; Waller EK; Langston AA -
Modulation of allo-reactivity of human PBMC by ex vivo treatment with fludarabine.
BLOOD Volume: 98 Page(s): 341B - 342B
11/16/2001 Authors: Lonial S; Torre C; Rosenthal H; Giver CR; Waller EK -
Rapid engraftment in recipients of CD34-selected PBSC transplants from matched related donors: A randomized study of cyclosporine/methotrexate or cyclosporine plus T-cell depletion for GVHD prophylaxis.
BLOOD Volume: 98 Page(s): 415A - 415A
11/16/2001 Authors: Schiller GJ; Pecora AL; Yanovich S; McCarty JM; Wagner JE; Waller EK; Pincus SM; McGuirk J; Wingard JR; Bachier C -
A cure for murine sickle cell disease (SCD) through stable mixed chimerism and tolerance induction after non-myeloablative conditioning and MHC-mismatched bone marrow transplantation.
BLOOD Volume: 98 Page(s): 736A - 736A
11/16/2001 Authors: Kean L; Durham M; Adams A; Hsu LL; Waller E; Dillehay D; Pearson T; Larsen C; Archer DR -
Immature DC1 and DC2 progenitors induce divergent allo-immune responses in autologous naive T-cells via indirect antigen presentation.
BLOOD Volume: 98 Page(s): 37B - 37B
11/16/2001 Authors: McDougal V; Rosenthal H; Torre C; Waller EK; Lonial S -
CD34 selection of peripheral blood progenitor cells for autologous transplant in myeloma and amyloidosis is associated with an increased risk of post-transplant varicella Zoster.
BLOOD Volume: 98 Page(s): 392A - 392A
11/16/2001 Authors: Smith KJ; Hamilton ES; Waller EK; Langston AA; Redei I; Lonial S; Heffner LT -
Yield of surveillance blood cultures in patients on corticosteroids for graft-versus-host disease.
BLOOD Volume: 98 Page(s): 362B - 362B
11/16/2001 Authors: Somani J; Teagarden D; Mossavi-sai S; Thourani J; Redei I; Lonial S; Waller EK; Langston AA -
Comparison of partially mismatched related donor (PMRD) graft vs volunteer unrelated donor (VUD) transplant for high risk hematologic malignancies.
BLOOD Volume: 98 Page(s): 386B - 386B
11/16/2001 Authors: Redei I; Langston AA; Jones M; Tanner A; Teagarden D; Lonial S; Cherry J; Bartlett V; Waller EK -
Salvage therapy with Infliximab for patients with severe acute and chronic GvHD.
BLOOD Volume: 98 Page(s): 399A - 399A
11/16/2001 Authors: Redei I; Knoche J; Tanner AR; Langston AA; Lonial S; Cherry JK; Sai SM; Waller EK -
Reducing nephrotoxicity in hematopoietic progenitor cell transplant recipients: Impact of initial versus delayed lipid based amphotericin B treatment.
BLOOD Volume: 98 Page(s): 207A - 207A
11/16/2001 Authors: Miller CB; Waller EK; Anaissie E; Dignani MC; McGuirk J; McSweeney PA; Cagnoni PJ; Fruchtman S; Klingemann H; Fleck PR -
Non-fatal Veno-Occlusive disease in non-transplant patients after treatment of relapsed AML with Mylotarg (gemtuzumab ozogamicin).
BLOOD Volume: 98 Page(s): 201B - 202B
11/16/2001 Authors: Langston AA; Feinstein B; Hutcherson D; Heffner LT; Redei I; Smith K; Lonial S; Bucur S; Jones A; Waller EK -
A randomized, placebo-controlled trial of GM-CSF as a vaccine adjuvant: Effect on cellular and humoral immune response
CLINICAL INFECTIOUS DISEASES Volume: 33 Page(s): 1154 - 1154
10/01/2001 Authors: Somani T; Lonial S; Rosenthal H; Waller EK -
Viral loads in a mouse model of lethal CMV infection following bone marrow transplantation: Allo- versus auto-BMT and adoptive allogeneic T-cell imunotherapy
TRANSFUSION Volume: 41 Page(s): 31S - 31S
09/01/2001 Authors: Roback JD; Gorechlad JW; Alexander S; Hillyer CD; Waller EK -
Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.
J Immunol Volume: 167 Page(s): 1103 - 1111
07/15/2001 Authors: Adams AB; Durham MM; Kean L; Shirasugi N; Ha J; Williams MA; Rees PA; Cheung MC; Mittelstaedt S; Bingaman AW -
Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.
Blood Volume: 97 Page(s): 2948 - 2956
05/15/2001 Authors: Waller EK; Rosenthal H; Jones TW; Peel J; Lonial S; Langston A; Redei I; Jurickova I; Boyer MW -
Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
Br J Haematol Volume: 113 Page(s): 224 - 230
04/01/2001 Authors: Lonial S; Bomberger C; Waller EK -
CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells.
Cancer Immunol Immunother Volume: 49 Page(s): 629 - 640
02/01/2001 Authors: Lopez RD; Waller EK; Lu PH; Negrin RS -
CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies.
Blood Volume: 96 Page(s): 3827 - 3837
12/01/2000 Authors: Lopez RD; Xu S; Guo B; Negrin RS; Waller EK -
Fludarabine treated donor lymphocytes enhance immune reconstitution without GvHD in allogeneic bone marrow transplantation.
BLOOD Volume: 96 Page(s): 173A - 173A
11/16/2000 Authors: Mittelstaedt SJ; Montes RO; Boyer MW; Waller EK -
Sequential CD34+and CD3+allogeneic cell transplants in patients with poor risk hematologic malignancies.
BLOOD Volume: 96 Page(s): 359B - 359B
11/16/2000 Authors: Waller EK; Langston AA; Bucur S; Lonial S; Cherry J; Feinstein B; Redei I -
Increased risk of thrombotic microangiopathy associated with high levels of tacrolimus in the post-transplant period.
BLOOD Volume: 96 Page(s): 334B - 334B
11/16/2000 Authors: Sonnier SA; Waller EK; Jones W -
Acyclovir (ACV)-resistant herpes simplex virus (HSV) after T- and B-cell depleted haploidentical stem cell transplantation (SCT).
BLOOD Volume: 96 Page(s): 193A - 193A
11/16/2000 Authors: Langston A; Redei I; Bucur S; Cherry J; Allen A; Thourani J; Teagarden D; Mossavi-Sai S; Hutcherson D; Waller EK -
Chronic GVHD (cGVHD) after matched sibling BMT is predicted by the number of transplanted donor NK-like T cells.
BLOOD Volume: 96 Page(s): 200A - 200A
11/16/2000 Authors: Langston A; Jones TW; Rosenthal H; Redei I; Lonial S; Waller EK -
A randomized study of G-CSF vs the combination of G-CSF/GM-CSF on mobilization of dendritic cells in peripheral stem cell grafts.
BLOOD Volume: 96 Page(s): 518A - 518A
11/16/2000 Authors: Lonial S; Rosenthal H; Feinstein B; Cherry J; Dunzel M; Waller EK -
Effective T cell depletion of G-CSF mobilized haploidentical PBSC graft with combined positive/negative immunomagnetic selection using Isolex 300i system version 2.5.
BLOOD Volume: 96 Page(s): 185A - 185A
11/16/2000 Authors: Redei I; Langston AA; Cherry JK; Hamilton ES; Jones ML; Waller EK -
Short-term in vitro exposure of allogeneic donor lymphocytes to fludarabine attenuates long-term immune functions.
BLOOD Volume: 96 Page(s): 618A - 619A
11/16/2000 Authors: Montes RO; Mittelstaedt SJ; Waller EK -
Modified perugia approach for haploindentical related donor transplantation for adults with poor prognostic hematologc malignancies.
BLOOD Volume: 96 Page(s): 209A - 209A
11/16/2000 Authors: Redei I; Langston AA; Cherry JK; Allen AJ; Bartlett VM; Waller EK -
Adoptive immunotherapy with fludarabine-treated cytomegalovirus primed donor splenocytes following MHC mis-matched allogeneic bone marrow transplantation in mice.
BLOOD Volume: 96 Page(s): 176A - 176A
11/16/2000 Authors: Roback JD; Mittelstaedt S; Hillyer CD; Waller EK -
Increased CMV-related mortality in allogeneic versus syngeneic bone marrow transplantation: Development of a murine model
TRANSFUSION Volume: 40 Page(s): 21S - 21S
10/01/2000 Authors: Roback JD; Hillyer CD; Mittelstaedt S; Waller EK -
New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.
Bone Marrow Transplant Volume: 25 Suppl 2 Page(s): S20 - S24
05/01/2000 Authors: Waller EK; Boyer M -
Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells.
Leukemia Volume: 14 Page(s): 412 - 418
03/01/2000 Authors: Boyer MW; Waller EK; Bray RA; Unangst T; Johnson TS; Phillips C; Jurickova I; Winton EF; Yeager AM -
High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma.
Leuk Lymphoma Volume: 36 Page(s): 497 - 502
02/01/2000 Authors: Lonial S; Jones TW; Devine S; Winton EF; Heffner LT; Smith KJ; Yeager AM; Waller EK -
Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature.
Bone Marrow Transplant Volume: 24 Page(s): 1337 - 1341
12/01/1999 Authors: Lonial S; Bilodeau PA; Langston AA; Lewis C; Mossavi-Sai S; Holden JT; Waller EK -
Allogeneic cell transplantation with rhG-CSF mobilized CD34+selected PBPC in conjunction with adoptive immunotherapy for adults with hematologic malignancy.
BLOOD Volume: 94 Page(s): 157A - 157A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Bucur S; Waller EK -
Busulfan/cyclophosphamide/fludarabine (BCF) conditioning prior to volunteer unrelated donor (VUD) bmt for patients with hematologic malignancies: A potential alternative to TBI containing preparative regimens.
BLOOD Volume: 94 Page(s): 567A - 567A
11/15/1999 Authors: Redei I; Langston AA; Bartlett V; Cherry JK; Allen A; Bucur S; Waller EK -
Autologous peripheral blood stem cell (PBSC) transplantation in AML: Outcome and flow cytometric analysis of the PBSC product.
BLOOD Volume: 94 Page(s): 398B - 398B
11/15/1999 Authors: Bucur SZ; Heffner LT; Langston AA; Redei J; Waller EK; Winton EF; Holden JT; Smith KJ -
Fludarabine attenuates the GvHD potential of allogeneic lymphocytes in BMT.
BLOOD Volume: 94 Page(s): 323B - 323B
11/15/1999 Authors: Mittelstaedt S; Montes R; Lonial S; Hairston R; Redei I; Boyer M; Waller EK -
Cultured CTL from haploidentical donors mediate GVL against relapsed ALL.
BLOOD Volume: 94 Page(s): 161A - 161A
11/15/1999 Authors: Boyer MW; Jurickova I; Jinks L; Burghardt D; Ogden A; Yeager AM; Waller EK -
Neurotoxicity associated with the use of tacrolimus following bone marrow transplantation: Noncorrelation with tacrolimus serum level.
BLOOD Volume: 94 Page(s): 334A - 334A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Waller EK -
Survival analysis of allogeneic bone marrow transplant (BMT) with and without GM-CSF support, a retrospective analysis of 182 patient.
BLOOD Volume: 94 Page(s): 151A - 151A
11/15/1999 Authors: Lonial S; Langston AA; Jones TW; Ennis SD; Waller EK -
Salvage therapy with mycophenolate mofetil (MMF) for patients with severe chronic GVHD.
BLOOD Volume: 94 Page(s): 159A - 159A
11/15/1999 Authors: Redei I; Langston AA; Cherry JK; Allen A; Waller EK -
Unrelated donor marrow transplantation using a preparative regimen of fractionated TBI, thiotepa, fludarabine, and ATG.
BLOOD Volume: 94 Page(s): 392B - 392B
11/15/1999 Authors: Langston AA; Redei I; Bucur S; Allen A; Cherry JK; Bartlett V; Waller EK -
Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
Blood Volume: 94 Page(s): 3222 - 3233
11/01/1999 Authors: Waller EK; Ship AM; Mittelstaedt S; Murray TW; Carter R; Kakhniashvili I; Lonial S; Holden JT; Boyer MW -
Expression of factor VIII by murine liver sinusoidal endothelial cells.
J Biol Chem Volume: 274 Page(s): 19587 - 19592
07/09/1999 Authors: Do H; Healey JF; Waller EK; Lollar P -
Expression of factor VIII by murine liver sinusoidal endothelial cells.
FASEB JOURNAL Volume: 13 Page(s): A1496 - A1496
04/23/1999 Authors: Do HV; Healey JF; Waller EK; Lollar P -
Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy.
Cytotherapy Volume: 1 Page(s): 21 - 29
01/01/1999 Authors: Waller EK; Barlett N; Chen CH; Mujic V; Sussman H; Toepker S; Grenier K -
Clinical use of irradiated donor lymphocytes in bone marrow transplantation.
Cancer Treat Res Volume: 101 Page(s): 267 - 282
01/01/1999 Authors: Ship AM; Waller EK -
The Hematopoietic Microenvironment: Heterogeneity of Bone Marrow Stromal Cells: Growth Properties and Cytokine Production by CD34+ and CD34- Stromal Sub-Sets.
Hematology Volume: 4 Page(s): 47 - 58
01/01/1999 Authors: Waller EK -
Molecular evidence that engagement of CD2/LFA-2 on activated human peripheral blood T-cells results in an IL-12-dependent preferential survival and expansion of gamma delta-T cells.
BLOOD Volume: 92 Page(s): 22A - 22A
11/15/1998 Authors: Lopez RD; Negrin RS; Xu S; Waller EK -
Survival after allogeneic bone marrow transplantation (BMT) is predicted by the number of transplanted donor CD34+ cells and donor dendritic cell progenitors (DCPs).
BLOOD Volume: 92 Page(s): 495A - 495A
11/15/1998 Authors: Waller EK; Lynn MJ; Boyer M; Jones TW; Rosenthal H; Langston A; Lopez R; Bucur S; Hillyer C; Redei I -
Vaccination with Td increases the frequency of antigen specific T-cells in the peripheral blood using a FACS analysis of intracellular IL2 expression.
BLOOD Volume: 92 Page(s): 339A - 339A
11/15/1998 Authors: Lonial S; Somani J; Resnick S; Kakhniashvili I; Rosenthal H; Ship A; Waller EK -
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
Blood Volume: 92 Page(s): 737 - 744
08/01/1998 Authors: Richardson PG; Elias AD; Krishnan A; Wheeler C; Nath R; Hoppensteadt D; Kinchla NM; Neuberg D; Waller EK; Antin JH -
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.
Blood Volume: 91 Page(s): 4427 - 4433
06/15/1998 Authors: Harker LA; Marzec UM; Novembre F; Sundell IB; Waller EK; Karpatkin S; McClure HM; Kelly AB; Stead RB -
Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors.
Blood Volume: 91 Page(s): 2588 - 2600
04/01/1998 Authors: Bomberger C; Singh-Jairam M; Rodey G; Guerriero A; Yeager AM; Fleming WH; Holland HK; Waller EK -
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.
Blood Volume: 90 Page(s): 5013 - 5021
12/15/1997 Authors: Miraglia S; Godfrey W; Yin AH; Atkins K; Warnke R; Holden JT; Bray RA; Waller EK; Buck DW -
The number of CD34+, CD38- cells in the graft predicts the kinetics of hematopoietic reconstitution following autologous or allogeneic bone marrow transplantation (BMT).
BLOOD Volume: 90 Page(s): 1753 - 1753
11/15/1997 Authors: Waller EK; Lynn M; Worford L; Winton EF; Redei I; Heffner T; Hillyer CD; Smith K; Bucur S; Lopez R -
Gamma irradiation activates NF-kappa B in human T-cells.
BLOOD Volume: 90 Page(s): 83 - 83
11/15/1997 Authors: Guerriero A; Boyer M; Waller EK -
Treatment of sever veno-occlusive disease (VOD) with defibrotide (DF): Compassionate use results in efficacy without significant toxicity in a high risk population.
BLOOD Volume: 90 Page(s): 1107 - 1107
11/15/1997 Authors: Richardson PG; Elias AD; Krishnan A; Wheeler C; Nath R; Hoppensteadt D; Waller EK; Antin JH; Soiffer RJ; Vredenburgh J -
7.5 Gy irradiation attenuates the graft-vs host disease (GvHD) potential of allogeneic lymphocytes while preserving anti-leukemic activity in pre-clinical and clinical studies.
BLOOD Volume: 90 Page(s): 2437 - 2437
11/15/1997 Authors: Waller EK; Redei I; Yeager AM; Winton EF; Heffner T; Hillyer CD; Carter R; Smith K; Holland HK; Connaghan G -
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.
BLOOD Volume: 90 Page(s): 754 - 754
11/15/1997 Authors: Harker LA; Marzec UM; Novembre F; Sundell IB; Waller EK; Karpatkin S; McClure HM; Kelly AB; Stead RB -
Randomized, double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients (Pts) following autologous bone marrow transplantation (ABMT).
BLOOD Volume: 90 Page(s): 2580 - 2580
11/15/1997 Authors: Beveridge R; Schuster M; Waller E; Stuart R; Abboud C; Cruickshank S; Menchaca D; Macri M; Connaghan DG -
Thrombopoietin is synthesized by bone marrow stromal cells.
Blood Volume: 90 Page(s): 3444 - 3455
11/01/1997 Authors: Guerriero A; Worford L; Holland HK; Guo GR; Sheehan K; Waller EK -
Platelet recovery following autologous bone marrow transplantation correlates with the content of CD34+, CD38-cells in the marrow graft.
EXPERIMENTAL HEMATOLOGY Volume: 25 Page(s): 598 - 598
08/01/1997 Authors: Waller EK; Worford LJ; Lynn M; Winton EF; Bray RA; Jones W; Rosenthal H; McCollum J; Holland HK; Yeager AM -
Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS).
EXPERIMENTAL HEMATOLOGY Volume: 25 Page(s): 621 - 621
08/01/1997 Authors: Holland HK; Bray RA; OToole K; Holden JT; Connaghan DG; Heffner LT; Waller EK; Winton EF; Yeager AM -
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Bone Marrow Transplant Volume: 20 Page(s): 219 - 225
08/01/1997 Authors: Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I -
Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions.
Bone Marrow Transplant Volume: 19 Page(s): 175 - 177
01/01/1997 Authors: Redei I; Waller EK; Holland HK; Devine SM; Wingard JR -
Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting
BLOOD Volume: 88 Page(s): 1616 - 1616
11/15/1996 Authors: Holland HK; Fleming WH; Waller EK; Connaghan DG; Geller RB; Wingard JR; Yeager AM -
Thrombopoietin (TPO) is synthesized by bone marrow stromal cells
BLOOD Volume: 88 Page(s): 238 - 238
11/15/1996 Authors: Guerriero A; Worford L; Sheehan K; Guo G; Holland HK; Hornkohl AC; Nichols J; Waller EK -
Ethnic and racial differences influence cell yields from bone marrow collections.
BLOOD Volume: 88 Page(s): 1576 - 1576
11/15/1996 Authors: Lin L; Holden JT; Jones TW; Holland HK; Yeager AM; Waller EK -
Allogeneic cytotoxic T lymphocytes can mediate graft-versus-leukemia without causing graft-versus-host disease.
BLOOD Volume: 88 Page(s): 964 - 964
11/15/1996 Authors: Boyer MW; Johnson TS; Yeager AM; Waller EK -
Cytokine upregulation of acute myeloid leukemia costimulatory function.
BLOOD Volume: 88 Page(s): 329 - 329
11/15/1996 Authors: Boyer MW; Johnson TS; Waller EK; Yeager AM -
Lymphoid reconstitution following autologous PBSC transplantation with FACS sorted CD34+ hematopoietic progenitors.
EXPERIMENTAL HEMATOLOGY Volume: 24 Page(s): 112 - 112
08/01/1996 Authors: Bomberger C; Rodey G; Guerriero A; Jairam M; Yeager AM; Fleming WH; Holland HK; Waller EK -
Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting.
EXPERIMENTAL HEMATOLOGY Volume: 24 Page(s): 631 - 631
08/01/1996 Authors: Holland HK; Fleming WH; Waller EK; Geller RB; Connaghan DG; Devine SD; Yeager AM -
Irradiated allogeneic donor lymphocytes have an anti-leukemic effect in mice without producing graft vs host disease.
EXPERIMENTAL HEMATOLOGY Volume: 24 Page(s): 363 - 363
08/01/1996 Authors: Waller EK; Murray TW; Boyer M -
Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice.
Blood Volume: 87 Page(s): 3237 - 3244
04/15/1996 Authors: Turner CW; Yeager AM; Waller EK; Wingard JR; Fleming WH -
Phase I trial of busulfan (BU), cyclophosphamide (CY), and diaziquone (AZQ) following autologous (AU) or allogeneic (AL) bone marrow transplantation (BMT).
BLOOD Volume: 86 Page(s): 831 - 831
11/15/1995 Authors: Devine SM; Dix SP; Geller RB; Holland HK; Colbaugh J; Connaghan DG; Fleming WH; Hillyer CD; Mullins R; Waller EK -
Allogeneic bone marrow transplantation across a major MHC barrier using T-cell depleted bone marrow in mice.
BLOOD Volume: 86 Page(s): 2271 - 2271
11/15/1995 Authors: Waller EK; Murray TW -
Consistent high frequency engraftment of human lymphocytes in BNX mice
BLOOD Volume: 86 Page(s): 641 - 641
11/15/1995 Authors: Fleming WH; Turner CW; Waller EK; Yeager AM -
Evaluation of supportive care guidelines for monitoring breast cancer bone marrow transplant (BMT) patients in the outpatient setting.
BLOOD Volume: 86 Page(s): 838 - 838
11/15/1995 Authors: Miyahara TT; Dix SP; Devine SM; Holland HK; Connaghan DG; Fleming WH; Geller RB; Heffner LT; Hillyer CD; Waller EK -
Tacrolimus (FK506) combined with methotrexate (MTX) is effective in preventing acute graft versus host disease (AGVHD) following related donor allogeneic bone marrow transplantation (BMT).
BLOOD Volume: 86 Page(s): 1569 - 1569
11/15/1995 Authors: Devine SM; Geller RB; Dix SP; Connaghan DG; Fleming WH; Heffner LT; Hillyer CD; Holland HK; Waller EK; Winton EF -
Transplantation of HLA-identical positively selected CD34+ cells of peripheral blood (PBSC) and marrow (BM) from related donors results in prompt engraftment and low incidence of GVHD in recipients undergoing allogeneic transplantation
BLOOD Volume: 86 Page(s): 1543 - 1543
11/15/1995 Authors: Holland HK; Bray AM; Geller RB; Devine SM; McCollum J; Connaghan DG; Fleming WH; Heffner LT; Hillyer C; Waller EK -
Risk factors for severe acute renal failure (ARF) after matched unrelated donor transplantation (MUDT).
BLOOD Volume: 86 Page(s): 1552 - 1552
11/15/1995 Authors: Redei S; Geller RB; Devine S; OToole K; Persons L; Holland HK; Connaghan G; Fleming WH; Heffner LT; Hillyer C -
DEVELOPMENTAL POTENTIAL OF DIFFERENT SOURCES OF HUMAN HEMATOPOIETIC STEM-CELLS
EXPERIMENTAL HEMATOLOGY Volume: 23 Page(s): 752 - 752
08/01/1995 Authors: FLEMING WH; WALLER EK; YEAGER AM; WINGARD JR; TURNER CW -
HIGH-MOLECULAR-WEIGHT DEXTRAN SEDIMENTATION ENHANCES RECOVERY OF HEMATOPOIETIC PROGENITORS FROM UMBILICAL-CORD BLOOD
EXPERIMENTAL HEMATOLOGY Volume: 23 Page(s): 913 - 913
08/01/1995 Authors: TURNER CW; YEAGER AM; PHARR J; WINGARD JR; WALLER EK; FLEMING WH -
Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
Blood Volume: 86 Page(s): 710 - 718
07/15/1995 Authors: Waller EK; Huang S; Terstappen L -
The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors.
Blood Volume: 85 Page(s): 2422 - 2435
05/01/1995 Authors: Waller EK; Olweus J; Lund-Johansen F; Huang S; Nguyen M; Guo GR; Terstappen L -
PREFERENTIAL EXPANSION OF A RARE POPULATION OF CD56+ T-CELLS FROM HUMAN PERIPHERAL-BLOOD - INVOLVEMENT OF IL-12 AND ADHERENT CELL COSTIMULATORY SIGNALS
FASEB JOURNAL Volume: 9 Page(s): A1024 - A1024
03/10/1995 Authors: LOPEZ RD; WALLER EK; NEGRIN RS -
THE CD34+, CD38-, HLADR- FRACTION OF HUMAN FETAL BONE-MARROW CONTAINS SEPARATE POPULATIONS OF HEMATOPOIETIC AND STROMAL PROGENITORS
BLOOD Volume: 84 Page(s): A417 - A417
11/15/1994 Authors: WALLER EK; OLWEUS J; LUNDJOHANSEN F; HUANG S; NGUYEN M; GUO GR -
CHANGES IN THE GROWTH-PROPERTIES OF CD34+, CD38-BONE MARROW PROGENITORS DURING HUMAN FETAL DEVELOPMENT
BLOOD Volume: 84 Page(s): A271 - A271
11/15/1994 Authors: WALLER EK; HUANG S; TERSTAPPEN L -
Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products.
J Virol Volume: 68 Page(s): 1165 - 1172
02/01/1994 Authors: Sen-Majumdar A; Weissman IL; Hansteen G; Marian J; Waller EK; Lieberman M -
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
Int J Radiat Oncol Biol Phys Volume: 28 Page(s): 119 - 126
01/01/1994 Authors: Wilder RB; McGann JK; Sutherland WR; Waller EK; Minchinton AI; Goris ML; Knox SJ -
EXPRESSION OF LINEAGE MARKERS ON NON-COMMITTED HEMATOPOIETIC PROGENITORS IN FETAL AND ADULT BONE-MARROW
BLOOD Volume: 82 Page(s): A10 - A10
11/15/1993 Authors: OLWEUS J; LUNDJOHANSEN F; HOFFMAN R; WALLER EK; TERSTAPPEN LWMM -
MEASUREMENT OF CIRCULATING CD34+ CELLS IN PATIENTS RECEIVING CYCLIC CHEMOTHERAPY
BLOOD Volume: 82 Page(s): A655 - A655
11/15/1993 Authors: WALLER EK; BARTLET N; CHEN A; CHEN CH; CHEN L; GRENIER K; LIN WW; SUSSMAN H; TOEPKER S; TERSTAPPEN LWMM -
Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.
Cell Volume: 74 Page(s): 833 - 843
09/10/1993 Authors: Dedera DA; Waller EK; LeBrun DP; Sen-Majumdar A; Stevens ME; Barsh GS; Cleary ML -
Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice.
Blood Volume: 82 Page(s): 247 - 261
07/01/1993 Authors: Waller EK; Ziemianska M; Bangs CD; Cleary M; Weissman I; Kamel OW -
Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.
J Exp Med Volume: 178 Page(s): 265 - 277
07/01/1993 Authors: Kraft DL; Weissman IL; Waller EK -
Human T-cell development in SCID-hu mice: staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy.
Blood Volume: 80 Page(s): 3144 - 3156
12/15/1992 Authors: Waller EK; Sen-Majumdar A; Kamel OW; Hansteen GA; Schick MR; Weissman IL -
Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis.
J Exp Med Volume: 176 Page(s): 399 - 405
08/01/1992 Authors: Lieberman M; Hansteen GA; Waller EK; Weissman IL; Sen-Majumdar A -
Growth of primary T-cell non-Hodgkin's lymphomata in SCID-hu mice: requirement for a human lymphoid microenvironment.
Blood Volume: 78 Page(s): 2650 - 2665
11/15/1991 Authors: Waller EK; Kamel OW; Cleary ML; Majumdar AS; Schick MR; Lieberman M; Weissman IL -
INVIVO GROWTH OF PRIMARY B-CELL NON-HODGKINS-LYMPHOMAS FOLLOWING HETEROTRANSPLANTATION IN SCID AND SCID-HU MICE
EXPERIMENTAL HEMATOLOGY Volume: 19 Page(s): 547 - 547
07/01/1991 Authors: WALLER EK; KAMEL OW; MALONEY DG; WEISSMAN IL -
Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells.
Biol Reprod Volume: 34 Page(s): 895 - 904
06/01/1986 Authors: Hettle JA; Waller EK; Fritz IB -
Chromosomal locations of human tissue plasminogen activator and urokinase genes.
Science Volume: 230 Page(s): 672 - 674
11/08/1985 Authors: Rajput B; Degen SF; Reich E; Waller EK; Axelrod J; Eddy RL; Shows TB -
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.
J Biol Chem Volume: 260 Page(s): 11223 - 11230
09/15/1985 Authors: Fisher R; Waller EK; Grossi G; Thompson D; Tizard R; Schleuning WD -
Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis.
J Biol Chem Volume: 260 Page(s): 6354 - 6360
05/25/1985 Authors: Waller EK; Schleuning WD -
RAT-TISSUE PLASMINOGEN-ACTIVATOR - ISOLATION, CHARACTERIZATION, MOLECULAR-CLONING AND NUCLEOTIDE-SEQUENCE
HAEMOSTASIS Volume: 14 Page(s): 57 - 57
01/01/1984 Authors: WALLER EK; PEARSON D; REICH E -
Complex-formation and inhibition of urokinase by blood plasma proteins.
Biochem J Volume: 215 Page(s): 123 - 131
10/01/1983 Authors: Waller EK; Schleuning WD; Reich E